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1. Introduction 
Schizophrenia is a complex clinical disorder that has a devastating impact on those who 
suffer from it. The onset of the illness typically occurs in the early twenties, when individuals with 
the disorder develop symptoms such as disorganized thinking and hallucinations, so-called 
“positive symptoms”. These symptoms can be managed by pharmacological intervention in 
some individuals. Other symptoms, like decreased speech production, decreased motivation, 
and a decreased interest in things, termed “negative symptoms”, are more persistent and 
currently have few effective therapeutic interventions. Further, individuals with schizophrenia 
experience deficits of cognition in the domains of attention and cognitive control, for example, 
which further complicate the lives and treatment outcomes for individuals with this disorder. 
Despite decades of study, the specific pathophysiology of schizophrenia and all of its varied 
symptoms remain elusive. However, recent advances in fields such as neuroimaging and 
neurochemical imaging have allowed for prominent pathophysiological theories to be 
experimentally tested.  
1.1. The Original Dopamine Hypothesis 
The dopamine hypothesis, for example, is one of the longest held theories of 
schizophrenia origin and was developed after the discovery of antipsychotic drugs (see Howes 
& Kapur, 2009 for a review). These drugs were found to reduce dopamine concentrations in the 
brain by increasing the metabolism of dopamine or blocking its reuptake. The original dopamine 
hypothesis suggested that excess transmission at dopamine receptors led to psychotic 
symptoms, and blockade, by antipsychotic drugs, could resolve these symptoms. While this was 
a first step to understanding the mechanisms underlying the clinical expression of schizophrenia, 
this hypothesis did not directly address the relationship between dopamine transmission and 
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neurodevelopmental deficits, the role that genetics played, what brain region was associated 
with disorder, or what way this disruption influences positive and negative symptoms of 
schizophrenia. It also did not connect the relationship between cognitive deficits associated with 
the disorder and the proposed etiological mechanism.  
1.2. The Revised Dopamine Hypothesis 
The revised dopamine hypotheses, put forth by Davis et al. (1991), was motivated by 
new evidence from postmortem and metabolite findings, imaging data, and animal work. This 
evidence called into question the somewhat simple mechanism of illness posited by the original 
dopamine hypothesis – that schizophrenia resulted from excess dopamine – and added 
specificity to the original hypotheses by suggesting that schizophrenia resulted from prefrontal 
hypodopaminergia related to a hypoactive mesocortical dopamine system, and subcortical 
hyperdopaminergia related to a hyperactive mesolimbic dopamine system (Davis et al., 1991). 
At the time this hypothesis was driven by evidence suggesting that dopamine function could 
vary by brain region, by findings from PET studies showing reduced cerebral blood flow in the 
frontal cortex, and from animal studies that provided evidence linking prefrontal dopamine 
function to striatal dopamine tone. The revised dopamine hypothesis also linked symptom 
expression to cortical and subcortical dopamine dysregulation, suggesting that the positive 
symptoms of schizophrenia resulted from striatal hyperdopaminergia and negative symptoms 
were more associated with frontal hypodopaminergia, as the mesocortical system has been 
implicated in regulating both cognition and motivation (see Cools, 2008 for a review). 
Interestingly, the mechanisms that regulate dopamine tone in these regions are not unrelated. 
Abi-Dargham (2004) discussed mechanisms that regulate dopamine transmission, stating that 
disruptions in glutamatergic neurotransmission could have exaggerated excitatory effects on 
dopamine neurons in the ventral tegmental area (VTA) while understimulating dopamine 
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neurons in the mesocortical dopaminergic pathway leading to cortical hypodopaminergia. 
Understimulation of D1 neurons in the cortex may reduce its inhibitory effect on subcortical 
dopamine, thereby contributing to subcortical hyperdopaminergia.  
1.2.1. The Revised Dopamine Hypothesis: Relationship to Cognitive Deficits 
The revised dopamine hypothesis also provided a mechanism that could possibly 
explain the type of cognitive impairment displayed by individuals with schizophrenia. A 
substantial amount of evidence from neuropsychological studies of patients with PFC lesions 
studies and electrophysiology studies of primates, and later neuroimaging studies of humans, 
have shown that the frontal cortex plays an important role in cognitive domains like executive 
functioning and working memory (Goldman-Rakic, 1995). Patients with schizophrenia have 
shown deficits in these same domains, though deficits in individuals with schizophrenia broaden 
to other domains that include processing speed, learning, and episodic memory (Dickinson, 
Ragland, Gold, & Gur, 2008; Reichenberg & Harvey, 2007). One common denominator for 
many of these tasks may be the requirement of executive control, which is necessary to guide, 
coordinate, and update behavior flexibly. Given the importance of the PFC in cognitive control 
processes like updating information, protecting against irrelevant information, and shifting from 
one information set to another (Linden, 2007), understanding the nature of prefrontal 
dysfunction during cognition has clear relevance for understanding performance deficits 
associated with schizophrenia. A recent meta-analysis of imaging data of patients with 
schizophrenia performing working memory and cognitive control tasks generally found evidence 
for reduced prefrontal engagement (Minzenberg, Laird, Thelen, Carter, & Glahn, 2009), which is 
consistent with the notion of hypofrontality. Another such meta-analysis did not find consistent 
evidence supporting hypofrontality of schizophrenia patients during working memory processing, 
nor did it find evidence supporting hyperfrontality (Van Snellenberg, Torres, & Thornton, 2006). 
Rather, this study found that prefrontal activation during working memory performance of 
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patients with schizophrenia varied across studies, demonstrating both increased activity and 
decreased activity compared to controls, and this activity was found to be moderated by the 
magnitude of performance differences between patients and controls (Van Snellenberg et al., 
2006).  
While the revised dopamine hypothesis was a step forward in conceptualizing 
schizophrenia etiology, it was not without its limitations. For example, many tenets of the 
hypothesis were based on animal research, as there was scant direct or indirect evidence in 
humans demonstrating low dopamine levels in the frontal cortex. Further, few studies at that 
time had demonstrated evidence of elevated dopaminergic striatal function in humans (recent 
studies, as discussed below, have provided some evidence for striatal dopamine dysregulation). 
However, it was influential for providing information about the locus of neural dysfunction and 
their relationship to symptom dysfunction. 
1.3. The Second Revision of the Dopamine Hypothesis 
Recently, a second revision of the dopamine hypothesis, proposed by Howes et al. 
(2009), shifted focus slightly from previous versions. It proposes, like previous theories, that 
striatal dopamine dysregulation is associated with psychosis in schizophrenia, but that a number 
of factors contribute to this dysregulation (for example, stress, drug use, genetics, fronto-
temporal dysfunction, etc). Further, dopamine dysregulation associated with psychosis does not 
appear to be well explained by differences of dopamine transporters or D2 type dopamine 
receptors availability, given that differences between patients and controls are inconsistently 
found and are of small effect (Howes et al., 2012). Instead, this recent revision to the dopamine 
hypothesis suggests that the locus of striatal dopamine dysregulation lies with presynaptic 
dopaminergic control, which impacts baseline synaptic dopamine levels, dopamine release, and 
dopamine synthesis capacity. Positron emission tomography (PET) studies examining 
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differences in dopamine synthesis capacity typically use radiolabeled-l-dihydroxyphenylalanine 
(L-DOPA), which is converted to dopamine and stored in presynaptic vesicles for release (see 
2006 for a review). A recent meta-analysis examining 618 patients with schizophrenia and 606 
controls, taken from 44 studies, demonstrated a highly significant elevation in presynaptic 
dopamine functioning in patients with a large effect size (Cohen d=0.79; Howes et al., 2012). 
This pattern was true even when excluding studies with patients receiving antipsychotic 
medication. At least one study of patients with schizophrenia has localized the dopamine 
synthesis capacity abnormality to the associative striatum, particularly the precommissural 
dorsal caudate (Kegeles et al., 2010). 
A number of studies over the past few years have provided robust support for the idea 
that presynaptic dopamine levels and dopamine release are associated specifically with 
psychotic symptoms and with antipsychotic use efficacy. For example, studies have found that 
dopamine synthesis capacity within the striatum is elevated for individuals who are at ultra-high 
risk for developing psychosis, that within the striatum increased synthesis capacity is localized 
to the associative striatum (Egerton et al., 2013; Howes et al., 2009), and capacity is positively 
correlated with the severity of prodromal symptomology but not with the severity of anxiety or 
depressive symptoms (Howes et al., 2009). There is evidence suggesting that dopamine 
synthesis capacity in the associative striatum may be able to predict the onset of psychosis, 
even amongst those individuals deemed to be at high risk for developing the disorder. Howes et 
al. (2011) assessed dopamine synthesis capacity of healthy participants and participants who 
were at ultra-high risk for psychosis, and then followed up with these participants 3 years later. 
Diagnostic interviews were done to determine who amongst the ultra-high risk group when on to 
develop a psychotic disorder. Subjects were then divided into three groups: healthy participants, 
those who were at high-risk for developing psychosis but did not transition, and those who were 
at high-risk for developing psychosis and did transition. The study found that participants who 
went on to transition to psychosis had significantly greater dopamine synthesis capacity within 
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the associative striatum than both the healthy and high-risk non-transition groups (Howes et al., 
2011). Dopamine synthesis capacity may also be able to predict which patients with 
schizophrenia will respond to antipsychotic medication from those who will be treatment 
resistant (Demjaha, Murray, McGuire, Kapur, & Howes, 2012), such that patients to respond to 
medication have significantly greater dopamine synthesis capacity than patients who do not and 
well controls. While patients who are resistant to antipsychotic medication intervention may not 
show differences of dopamine synthesis capacity when compared with controls and patients 
who do respond to medication use, there is some early evidence to suggest that treatment 
resistant patients may have increased glutamate levels, particularly within the anterior cingulate 
(Demjaha et al., 2014) 
The second revision of the dopamine hypothesis also de-emphasizes the role that the 
prefrontal cortex has on symptom expression, as the evidence supporting prefrontal 
hypodopaminergia is inconclusive. For example, dopamine transmission in the prefrontal cortex 
is mainly mediated by D1 receptors. While D1 dysfunction has been linked to cognitive 
dysfunction and negative symptoms in schizophrenia (Goldman-Rakic, Castner, Svensson, 
Siever, & Williams, 2004), studies examining the relationship between D1 receptor levels, 
schizophrenia symptoms, and cognition have either found no difference between patients and 
controls (Karlsson, Farde, Halldin, & Sedvall, 2002), decreased receptor density (Okubo et al., 
1997), or increased D1 receptor density (Abi-Dargham et al., 2002; Berridge, 2007). Given 
these inconsistent results, the second revision focuses its attention on presynaptic dopamine as 
a mechanism leading to striatal dopaminergic dysregulation in schizophrenia.  
1.3.1. Motivational Incentive Salience and Schizophrenia 
The second revision of the dopamine hypothesis goes on to link its neurochemical 
hypothesis with the clinical phenomena of schizophrenia by considering the motivational 
incentive salience literature. The motivational salience hypothesis suggests that dopamine 
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mediates the conversion of an external stimulus from a neutral representation into one that is 
attractive or aversive (Berridge & Robinson, 1998). In addition to motivational salience there are 
other competing theories that describe the causal contribution mesolimbic dopamine activity has 
on reward and motivation, including theories of hedonia or ‘liking’ as well as learning and reward 
prediction theories (Berridge, 2007). Berridge (2007) reviewed these theories and the evidence 
to support them and suggested that, given the evidence, dopamine is not necessary for 
experiencing hedonia or for learning via prediction signals (Berridge, 2007). However, of the 
three theories dopamine was necessary to produce ‘wanting’ and dopamine activation was 
sufficient to assign incentive salience to external, neutral, stimuli (Berridge, 2007). While this 
argument suggests that, with regard to reward and motivation, dopamine may be more 
important for motivational incentive salience, it does not suggest that dopamine is unimportant 
for hedonics and learning. Rather, it suggests that the role of dopamine in the attribution of 
salience provides an interface where hedonics, reward prediction, and learning mechanisms 
allow for an organism to focus its efforts on what it determines to be valuable and facilitates 
motivational drives to action. The importance of dopamine for “wanting” or incentive salience is 
discussed in a review by Palmiter (2008), in which he examines the literature of genetically 
engineered mice that lack tyrosine hydroxylase (responsible for catalyzing the conversion of L-
tyrosine to L-DOPA, precursor to dopamine) in all dopaminergic neurons. These mice, he 
observes, become hypoactive and aphagic (refusal to swallow), and starve by the time that they 
reach 4 weeks of age. Mice that are dopamine-depleted are not motivated to engage in goal-
directed behaviors, but still have a preference for rewarding foods, like sucrose, and can still 
learn from conditioning. Restoring dopamine selectively in the dorsal striatum is sufficient to 
allow feeding, locomotion, and it appears to restore motivation to engage in goal-directed 
behaviors.  
Under normal circumstances, dopamine mediates the acquisition of motivational 
salience assignment in response to a stimulus based on a person’s experience or preference, 
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but it does not create this process independent of stimulus. In psychosis, however, the revised 
dopamine hypothesis suggests that dysregulated dopamine transmission leads to stimulus-
independent release of dopamine, which then leads to aberrant salience assignment to external 
stimuli as well as internal representations (Kapur, 2003). As such, this hypothesis proposes that 
dysregulated dopamine release contributes directly to the formation of delusional symptoms via 
inappropriate attribution of salience to “neutral” events in the environment.  More specifically, 
the psychotic experience is thought to evolve in stages, where initially an individual with 
schizophrenia may simply have a heightened “awareness”, where previously irrelevant stimuli in 
the environment become relevant. Subsequently, these individuals may feel driven to act on 
and/or explain the newly relevant phenomenon (G. Roberts, 1992) at which point a top-down 
cognitive explanation is imposed. Over time, the delusional framework is created. With 
hallucinations a similar process may take place but with the initial aberrant salient experience 
being internal representations – internal thoughts, guilt, etc (Kapur, 2003). This recent revision 
to the dopamine hypothesis does describe how incentive salience models might explain 
negative symptoms, suggesting that dopamine dysregulation diminishes reward signals thereby 
producing symptoms like anergia and anhedonia in a similar way that dopamine depletion 
affects mice, but Kapur (2003) suggests that incentive models may be more appropriate for 
explaining positive symptoms. 
1.3.2. Studies Examining Aberrant Incentive Salience and Schizophrenia 
The formation and expression of aberrant salience assignment is thought to involve the 
dorsal and ventral striatum, which receives inputs dopaminergic inputs from the substantia nigra 
and VTA, respectively. As discussed above, glutamatergic projections from the PFC, amongst 
other regions, to the VTA also influence dopaminergic input to the ventral stratum. Few studies 
have examined the relationship between aberrant incentive salience, schizophrenia symptom 
expression, and brain functioning. Studies of healthy participants have shown that the ventral 
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striatum plays an important role in associative learning, where participants learn to associate 
relevance to a neutral stimulus after repeated paring with an unconditioned stimulus, using both 
appetitive and aversive stimuli (McClure & Lieberman, 2003; O'Doherty, Dayan, Friston, 
Critchley, & Dolan, 2003). For patients with schizophrenia there is behavioral evidence 
suggesting they exhibit aberrant salience when performing a salience attribution test, which was 
particularly evident in patients with delusions (Roiser et al., 2009), and there is neuroimaging 
evidence that this aberrant salience assignment is associated with activity in the ventral striatum 
in both medicated (Jensen et al., 2008) and unmedicated (Esslinger et al., 2012) patient 
populations. Thus, there is evidence that 1) patients with schizophrenia, thought to have 
dysregulated dopaminergic activity, demonstrate aberrant salience assignment behaviorally; 
and 2) that this aberrant salience assignment is associated with activity in the ventral striatum. 
However, a number of studies suggest that the locus of the major dopamine abnormality of 
patients with schizophrenia compared to controls is in the dorsal striatum. What, then, is the 
relationship between dysregulated dopamine, aberrant salience, and dorsal striatal functioning? 
Moreover, is there are relationship between aberrant salience, dorsal striatal functioning, and 
other symptoms of schizophrenia like deficits of cognition? 
1.4. Cognitive Control and Schizophrenia: Background 
While patients with schizophrenia display cognitive deficits in a variety of domains, it 
may be the case that a common denominator for these deficits is impaired cognitive control. In 
fact, areas of relative cognitive strengths in schizophrenia are in tasks or domains that are not 
dependent on executive control. For example, meta-analytic studies have shown that effect size 
differences on tasks of simple attention are smaller than those of complex working memory 
tasks and executive functioning tasks (Dickinson et al., 2007; Reichenberg & Harvey, 2007). 
Further, a meta-analysis of a canonical task of executive control (the Wisconsin Card Sorting 
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Task; WCST) has shown that patients with schizophrenia are severely impaired (Dickinson, 
Ramsey, & Gold, 2007) and that their performance distinguishes them not only from controls, 
but other psychiatric groups as well (Johnson-Selfridge & Zalewski, 2001).  
Cognitive control is thought to be a critical aspect of cognition as it allows for goal related 
information to be selected for maintenance and maintained, protected against interference, and 
updated when appropriate (Braver & Cohen, 2000; J. D. Cohen, Braver, & O'Reilly, 1996; 
Norman & Shallice, 2000; Oberauer, 2009; Randall & Munakata, 2000). This goal directed 
behavior might depend upon reward signals that have a neuromodulatory effect on neural 
processing in the prefrontal cortex (Braver & Cohen, 2000). Theoretical models of cognitive 
control dysfunction in schizophrenia (e.g. Braver, Barch, & Cohen, 1999) have suggested that 
disrupted dopaminergic signaling associated with schizophrenia interfere with a gating 
mechanism that facilitates the control of information during cognitive control. More specifically, 
Braver et al. (1999) suggest that dopamine activity signals the presence of goal relevant 
information, which allows this information to be updated or gated into active memory, and 
dysregulated dopamine signaling can disrupt the control of information gated into active memory 
as well as the protection of maintained information against irrelevant information. One problem 
with theories that propose updating of prefrontal information representations via direct 
mesocortical dopamine input is that this signal updates the PFC globally, which would make 
selective updating of prefrontal information representations difficult. Another indirect route by 
which dopaminergic signals may impact prefrontal control processing is through 
nondopaminergic inputs (e.g. basal ganglia-thalamocortical loops). One theory, originally 
proposed by Frank et al. (2001) addresses the global dopamine updating problem by 
suggesting that the basal ganglia, via guidance by dopaminergic inputs, may work to gate 
information in specific areas of the cortex during cognitive control.  
1.4.1. Basal Ganglia Involvement in Cognitive Control 
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Frank et al. (2001) also proposes that cognitive control tasks, like working memory tasks, 
require rapid updating, maintenance, interference control, and a mechanism of gating. This 
model suggests that these processes are executed by an interaction between the basal ganglia 
and the frontal cortex, such that the frontal cortex uses continuously firing activation to maintain 
information over time and the basal ganglia fires only to trigger appropriate task related updating. 
Further, this model assumes that separate memory representations are possible and are 
represented via the striped micro-anatomy of the PFC (from Hazy, Frank, & O'Reilly, 2006). 
These stripes are characterized by small groups of interconnected neurons somewhat isolated 
from one another, which may protect them from interference from representations in nearby 
stripes. According to the model selective updating is accomplished via independent, updatable 
parallel loops known to exist in between the basal ganglia and the PFC (Middleton & Strick, 
1994) that are selective to anatomical stripes in the PFC. By incorporating the stripe-based 
gating architecture this model attempts to address the global updating problem of other 
dopamine-based gating models. 
The mechanisms that allow gating to occur in the Frank (2001) model are considered an 
evolutionary extension of the same mechanisms involved in the motor control system: the direct 
and indirect pathways (Hazy, Frank, & O'Reilly, 2007; Smith, Bevan, Shink, & Bolam, 1998). In 
the motor domain, learned action history shapes reward signaling to the basal ganglia, which 
then inhibits or disinhibits frontal motor representations to allow an action to occur and to inhibit 
unwanted actions. Neurons in the direct pathway, or the Go pathway, and the indirect pathway, 
or the NoGo pathway, originate in the caudate. The Go pathway is sensitive to D1 receptor 
stimulation and the NoGo pathway is sensitive to D2 receptor stimulation. When neurons in the 
Go pathway fire they inhibit the substantia nigra pars reticulate (SNr), which inhibits the 
thalamus, when then releases regions of the cortex from its tonic inhibition. When neurons in 
the NoGo pathway are tonically active, and inhibit the globus palladus, which disinhibits the SNr, 
and thus allows for tonic inhibition of the cortex via the thalamus. Increased activity of the Go 
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pathway is associated with facilitation of movement and increased activity of the NoGo pathway 
is associated with the inhibition of movement (Smith et al., 1998). Disorders of motor 
dysfunction, like Parkinson’s, are the result of an imbalance of Go and NoGo pathway activity, 
where a depletion of dopamine in the striatum diminishes Go pathway activity and impairs 
movement initiation. Similarly, these pathways may inhibit and disinhibit regions of the frontal 
cortex responsible for representing target information necessary to mediate cognitive control 
demands. That is, Go pathway signals that are triggered by increases in dopamine in response 
to target stimuli and this Go activity facilitates information updating in the cortex. NoGo activity, 
on the other hand, is tonically active and facilitates the maintenance of information over time. 
Further, the model predicts that recurrent maintenance processes in the prefrontal cortex will 
demonstrate transient activity when a task irrelevant distractor is presented, but regions in the 
basal ganglia will not activate because the distractor fails to initiate an update signal (also see 
Gruber, Dayan, Gutkin, & Solla, 2006). Thus, according to the model, during the execution of 
updating task relevant information one would expect to see “Go” activity in both the striatum and 
the frontal cortex, but during the presentation of task irrelevant distracters, a “NoGo” condition, 
one would not expect to see increased activity in the striatum but transient activity in the 
prefrontal cortex.  
Interestingly, few studies have explicitly examined the role of the striatum during 
updating task performance. Updating is thought to be an important part of executive functioning 
(Miyake et al., 2000; Oberauer, 2009) and can be described as the overwriting of active memory 
representations with new, task relevant information. It is a construct that has been shown to be 
separable from other cognitive constructs associated with executive functioning. For example, 
Miyake (2000) used a latent variable analysis and found that performance on updating tasks 
were dissociable from performance on tasks that required shifting between mental sets, or tasks 
that required the inhibition of proponent processes. Given the apparent construct validity for 
these updating tasks Collette et al. (2007) conducted a functional imaging study to identify 
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regions of the brain that activated similarly during updating processing. By adapting updating 
tasks from the Miyake (2000) study and using conjunction analysis they found a large cerebral 
network including the left frontopolar region and left middle frontal gyrus was common to the 
different updating tasks used in the study, although activation in some regions was more 
specific to the particular task used. They did not find basal ganglia involvement during updating 
task performance. However, because such a large number of cerebral areas were involved in 
updating they concluded that the unitary nature of the updating construct may be questionable. 
Alternatively, they note that in addition to updating the tasks that were used in the study 
required encoding, the maintenance of information, sequencing, and a response. As such, using 
an updating task that attempts to separate these processes may better capture brain activity 
associated with updating processing.  
A study by Roth et al. (2006) used a visual updating task that was designed to separate 
maintenance activity from updating activity. They used a mixed-event blocked design and 
deconvolution analysis to estimate time courses, and also found that a distributed network of 
regions was associated with updating (greater activity during updating than during maintenance 
activity). Included within this network of regions was a region in the left lateral dorsal striatum. 
While this study provided some support for the involvement of the basal ganglia in updating, a 
number of other regions also showed similar patterns of activity (e.g. middle frontal gyrus) and 
there was no evidence to suggest that one region contributed differently to update processing 
than another.  
Another study by McNab & Klingberg (2008) investigated the neural basis for accessing 
control to working memory storage. Their results were consistent with the idea that an 
individual’s working memory capacity is determined by their ability to selectively filter irrelevant 
distracters, as they found that middle frontal gyrus and globus pallidus activity were significant 
predictors of working memory capacity, and globus pallidus activity was negatively correlated 
with distracter storage. That is, they suggest that globus pallidus activity actively filters 
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distracting information, thus freeing up working memory capacity. As globus pallidus activity 
decreases the number of distracting items stored increases. They suggest that the globus 
pallidus functions as a filter mechanism for working memory, however their results did not 
extend to the dorsal striatum. 
To better examine the dynamic activations between the cortex and the basal ganglia 
during cognitive control, a study would need to utilize a single task that not only incorporates 
important component processes of cognitive control, but one that also isolates these elements 
from one another. Such a task was used in my prior work (Ceaser et al., in prep). In this 
previous study we used an event-related imaging design to isolate task events in time as well as 
a novel task of updating that separately examined updating, interference control (the protection 
of stored information against task irrelevant information), and simple maintenance. We found a 
dissociation between subcortical and cortical regions of the brain during updating and 
interference control, such that both cortical and subcortical regions displayed robust updating 
activity, but only cortical regions demonstrated increased activity when compared to a “do 
nothing” condition. The striatal regions that showed a main effect of condition (the conditions 
being update, interference control, and simple maintenance) and an interaction of condition by 
time (specifically, the time window encompassing the presentation of an update cue and a 7 
second delay prior to the presentation of a probe) were almost entirely left lateral, and with the 
exception of one region in the caudate were all dorsal caudate or dorsal caudal putamen (dorsal 
were those with a z > 2 and caudal regions were those with a y > 0). This finding suggests while 
both cortical and subcortical regions are involved in updating processing, the patterns of activity 
in frontal cortex and striatum are dissociable, and are generally consistent with the pattern of 
effects one would predict from the Frank (2001) model. 
1.5. Aberrant Salience and Cognitive Control: Proposed Study 
While there is consistent evidence suggesting that the dorsal striatum is the locus of the 
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largest dopamine abnormality for patients with schizophrenia, evidence suggesting that this 
disruption of striatal functioning may lead to aberrant salience assignment, and some evidence 
suggesting the striatum may function as a cognitive gating mechanism that is likely dependent 
upon well regulated dopaminergic signaling, few studies if any have found a relationship 
between these findings. Thus, the question remains: Is there are relationship between aberrant 
salience, dorsal striatal functioning, and other symptoms of schizophrenia like deficits of 
cognition? Like other models describing the mechanisms of cognitive control impairment in 
schizophrenia (Braver & Cohen, 1999), the Frank model also predicts that dysregulated 
dopamine will disrupt the gating signal, in this case Go signal activity, and lead to impaired 
cognitive control. Dopamine dysfunction could cause the inappropriate updating of task 
irrelevant information (inappropriate Go signaling), or weaken maintenance signaling (disrupted 
NoGo signaling) for patients with schizophrenia. Both impairments could lead to increased 
distractor susceptibility for patients. If, given our previous work (Ceaser et al., in prep), the basal 
ganglia are selectively involved in updating we predict that patients, who have dysregulated 
striatal dopamine signaling, demonstrate increased activity compared to controls when 
presented with task irrelevant distractors. Further, it may also be the case that there is a 
relationship between aberrant salience assignment, thought to be associated with positive 
symptoms of schizophrenia like delusions and hallucinations, and disrupted cognitive control 
gating that leads to performance deficits during distractor resistance. In fact, evidence for this is 
provided by a recent study by Morris et al. (2012), who found that positive symptoms scores of 
schizophrenia were related to learned irrelevance, and that even within the patient group high 
positive symptom patients were significantly worse at ignoring irrelevant information than low 
positive symptom patients. One difficulty with linking impaired cognitive control to impaired 
subcortical DA function and aberrant salience in schizophrenia is that the majority of prior 
studies examining cognitive functioning in schizophrenia have not found a relationship to global 
measures of positive symptoms (Breier, Schreiber, Dyer, & Pickar, 1991; Nuechterlein et al., 
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2011; Ventura, Hellemann, Thames, Koellner, & Nuechterlein, 2009). However, few studies 
have specifically examined the relationship between specific subcomponents of cognitive 
control and the specific aspects of positive symptoms that the second revision of the dopamine 
hypothesis would predict to be related to abnormal (i.e. aberrant salience).  
Using a novel task that is specifically designed to better isolate different aspects of 
cognitive control (e.g. updating, maintenance, and interference control), we will test whether or 
not patients demonstrate disrupted basal ganglia activity compared with controls during 
cognitive control performance, and determine whether or not these disruptions in brain activity 
are associated with particular aspects of behavioral performance as well as clinical symptoms of 
schizophrenia, specifically aberrant salience, delusions, and hallucinations. 
1.6. Specific Aims 
Specific Aim 1: Test the hypothesis that individuals with schizophrenia demonstrate 
dysregulated striatal activity during updating and interference control and that striatal 
activity predicts performance deficits. Using a novel task of cognitive control and functional 
magnetic imaging, I will scan both patients and controls to examine cortical and subcortical 
brain activity changes during task performance. Given evidence that patients with schizophrenia 
have dysregulated dopamine activity in the striatum I predict that individuals with schizophrenia 
will show: 1) reduced striatal signal during updating which will be associated with poorer 
updating performance; and 2) increased striatal activity during the presentation of irrelevant 
distractors, which will be associated with poorer distracter resistance. 
Specific Aim 2: Test the hypothesis that in individuals with schizophrenia, increased 
striatal activity during distracter presentation will be positively associated with aberrant 
salience symptoms, delusions, and hallucinations of patients with schizophrenia. Using a 
variety of clinical tools to assess schizophrenia symptomology (including the Scale for the 
Assessment of Negative Symptoms, SANS; the Scale for the Assessment of Positive Symptoms, 
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SAPS; and the Aberrant Salience Inventory, ASI) I will examine the relationship between 
symptom scores and striatal activity during distracter presentation. Symptom scores of 
delusions and hallucinations will be obtained from the SAPS. The ASI will be used to assess 
overall aberrant symptom salience. I predict that increased striatal activity will be associated 
with increased symptom severity of delusions, hallucinations, and the index of aberrant salience 
from the ASI. Further, increased symptom severity will be associated with increased intrusion 
errors during distractor presentation.  
2. Methods 
Participants were recruited through the Conte Center for the Neuroscience of Mental 
Disorders (CCNMD) at Washington University in St. Louis. We recruited 56 participants (30 
individuals with schizophrenia and 26 healthy controls). Of those participants, 4 were excluded 
from data analysis because of excessive head movement while in the scanner, 9 were excluded 
for not completing both phases of the study, and 1 healthy control was excluded because of 
aberrant behavioral performance (determined by mahalnobis distance, described below). This 
left us with 22 participants in the patient group and 20 participants in the healthy control group. 
Patients were diagnosed using the Structured Clinical Interview for DSM-IV (SCID-IV; First, 
Spitzer, Gibbon, & Williams, 2002). These interviews were conducted by a master’s-level 
clinician, who completed SCID-IV training and participated in regular diagnostic training 
sessions as part of the CCNMD. Controls were given a Mini-International Neuropsychiatric 
Interview (MINI; Sheehan et al., 1998) to determine the presence of a history of mental illness. 
Exclusion criteria for controls included a lifetime history of any psychiatric disorder and having a 
first-degree relative with a psychotic disorder. Participants in either group were excluded if they 
met criteria for substance abuse or dependence within the past 6 months, have a clinically 
unstable or severe medical disorder, a medical disorder that would confound the assessment of 
psychiatric diagnosis or render research participation dangerous, had head trauma with loss of 
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consciousness, or met DSM-IV criteria for mental retardation. Patients were stable on 
antipsychotic medication doses for at least 2 weeks before participating in the study.  
All participants were given the Vocabulary and Matrix reasoning subtests from the 
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997) to assess both 
verbal and non-verbal intelligence. Socioeconomic status was assessed by asking participants 
two open-ended questions for each parent about what the parent currently does and what they 
did for a living most of their life. Parental education was assessed by asking participants open-
ended questions about the highest level of education each parent attained. The answers were 
classified using a scale similar to the British Registrar General’s social classification of 
occupations where occupations range from 0 (low occupational status) to 45 (high occupational 
status). Given that disease progression and cognitive disturbances associated with 
schizophrenia risk may impair educational attainment and achievement we focused on parental 
socioeconomic status and parental education as they may be a more appropriate way to assess 
developmental exposure to educational opportunities that could influence cognitive function 
(Resnick SM, 1992). 
2.1. Clinical Rating Scales 
 We conducted assessments of the current level of clinical expression in both patients 
and controls. Clinical symptoms of patients were assessed using the Scale for the Assessment 
of Negative Symptoms (SANS; Andreasen, 1983) and the Scale for the Assessment of Positive 
Symptoms (SAPS; Andreasen, 1984). These assessments were conducted by a master’s-level 
clinician. All participants also completed the Chapman Psychosis Proneness Scales (L. J. 
Chapman, Edell, & Chapman, 1980), which included the Perceptual Aberration Scale, the 
Magical Ideation Scale, the Physical Anhedonia Scale, and the Social Anhedonia Scale.  
We assessed aberrant salience specifically using the Aberrant Salience Inventory (ASI). 
The ASI was developed to asses the unusual or inappropriate assignment of salience, 
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significance, or importance to non-salient stimuli (Cicero, Kerns, & McCarthy, 2010). It consists 
of 29 items created to capture the phenomenological descriptions of the initial experience of 
psychosis in the literature (Kapur, 2003; Parnas, Handest, Saebye, & Jansson, 2003). Items for 
the ASI were generated by Cicero et al. (2010) based on the phenomenological descriptions of 
the initial experience of psychosis in the literature, descriptions of the prodromal phase of 
schizophrenia, and transcripts of interviews of people with schizophrenia. Cicero et al. (2010) 
found that the ASI was strongly, positively correlated with scales assessing psychotic-like 
experiences, including magical ideation and perceptual aberration, and other scales measuring 
psychosis-proneness. The ASI was also found to be positively correlated with social anhedonia, 
but the correlation was weaker than the correlation between ASI and other scales assessing 
psychoisis-proneness. The weaker relationship between ASI and anhedonia was predicted 
given previous work demonstrating a weaker relationship between psychosis-proneness and 
social anhedonia (Kwapil, 1998). Further, the ASI was found to be elevated in healthy 
individuals with elevated psychosis proneness as well as participants with a history of psychosis, 
even when comparing them with a psychiatric comparison group (Cicero et al., 2010). The utility 
of the ASI, compared to other scales measuring psychosis proneness, is in its specificity. While 
other scales, including magical ideation and perceptual aberration (CHAPMAN), the Structured 
Interview for Prodromal Syndromes (SIPS; Kwapil, 1998), and the Schizotypal Personality 
Questionnnaire (SPQ; Raine, 1991), contain items that are similar to aberrant salience there are 
other items that may tap into constructs that are related, but peripheral to the core construct of 
aberrant salience.  
2.2. Task Design and Stimuli 
 While in the scanner subjects completed a modified Sternberg-type delayed match-to-
sample working memory task. The task contains a two-item working memory load consisting of 
two complex geometric shapes (Attneave & Arnoult, 1956) that were generated using a Matlab 
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algorithm (Collin & McMullen, 2002). These stimuli were chosen because they may be more 
difficult to encode than words or numbers, and thus we hoped to restrict encoding strategies 
used by subjects. By doing so we hoped that the level of difficulty for both patient and control 
groups would be more comparable, as individuals with schizophrenia and controls would be less 
likely to spontaneously engage in such verbal maintenance strategies. The shapes were white 
on a black background and each trial of the task consisted of three distinct, temporally isolated, 
periods: memory set presentation, update cue presentation, and probe presentation (see Figure 
2.1). During the memory set participants were presented with two shapes, one after another, 
framed in a blue box. The shapes were presented for 1.5 seconds each. Participants were 
asked to memorize these shapes in the order that they were presented. After the second shape 
participants saw a fixation cross in the center of the screen that was presented for 7 seconds. 
Participants were instructed to focus on the cross while maintaining the previously presented 
items (Delay 1 in Figure 2.1). After the first delay participants were presented with the update 
cue items: 2 green or red boxes presented one after another for approximately 1.5 seconds 
each. If the boxes were green (an Upgreen trial, part A in Figure 2.1) and a shape appeared in 
one or both of the boxes, participants were asked to replace the original shape that appeared in 
that position (the first or second shape that was framed in blue during memory set presentation). 
During an Upgreen trial participants made either a partial (one shape, either in the first or 
second position) or a whole update of the original shapes presented during the memory set. If 
the boxes were red (a Upred trial; part B in Figure 2.1) participants were asked to ignore any 
new shapes that were presented and continue remembering the original shapes framed in blue. 
If, during the update cue, both boxes were empty (an Upempty trail; part C in Figure 2.1) 
participants were not required to do anything but maintain the original shapes of the memory set 
that were framed in blue. Boxes during Upempty trials could be either red or green. Because no 
new shape was presented participants were instructed that the color of the boxes was irrelevant.  
 At the presentation of the probe, participants were presented with one shape, the word 
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“Correct?” appeared at the top of the screen, and at the bottom the word “Yes” appeared on the 
right and the word “No” appeared on the left. Participants were asked to make a button press if 
the shape that was presented matched one of the two shapes that they were currently 
remembering. There were a total of 120 trials used in the task (52 Upgreen, 48 Upred, and 20 
Upempty; Appendix Table F). A number of differing probe types were used in the task to capture 
a variety of errors that an individual could make during task performance. For example, during 
Upgreen trials the participant was probed with probed with the item they should have updated. 
This trial was called an “Update” trial. A correct response indicates that an appropriate update 
was made and that the new information was encoded into memory. There were a total of 20 
Update trials. Another Upgreen probe we used was called a “Resist Maintenance” trial, and 
participants were probed with the shape in the original memory set that should have been 
replaced by the new item during the update cue. A correct rejection of this shape indicates that 
the subject rejected this item as one of the two correct shapes, but a response of “yes” to this 
items suggests that the participant incorrectly maintained this item in the target set. This type of 
trial is called a Resist Maintenance trial because participants must resist maintaining this shape 
when they were being asked to replace it during the update cue. There were a total of 20 Resist 
Maintenance trials. For trials where the participant was asked to ignore information (Upred), we 
probed participants with one shape from the original memory set. A correct response on this trial 
type suggests that the participant was able to maintain information even when presented with 
task relevant distracters during the update cue period. These trials are called “Resist Distracter” 
trials and there were 20 of these trials during the task. Another probe type that was used during 
Upred trials involved participants being probed with a shape that they were asked to ignore 
during the update cue. These trials are called “Resist Distracter Lure” trials and there were also 
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Figure 2. 1 Controlled Update Task Design 
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20 trials of this type in the task. A correct response during this trial type indicates that a 
participant correctly rejected a shape that did not match one of the to-be-remembered shapes. 
An incorrect response on this trial type suggests that the participant inappropriately encoded 
this shape into memory. Dysregulated salience assignment may lead to increased errors on this 
trial type, as task information designated as irrelevant may be inappropriately assigned some 
relevance. Finally, for Upempty trials participants were probed with an item from the original 
memory set. There were 14 of these trials and they are called “Maintenance” trials. A correct 
response indicates that the participant correctly maintained this information over the course of 
the trial. In addition to the probes used in the above mentioned trials participants were probed 
with shapes that were not presented previously. These trials are called “Novel Probe” trials (26 
trials of this type) and were included to ensure that participants could reject probes that were 
obviously incorrect, and thus these trials gave us a measure of how well participants understood 
the task’s instructions.  
2.3. fMRI Acquisition  
 Structural and blood-oxygen-level-dependent (BOLD) data was acquired with a 3T Tim 
TRIO scanner (Siemens, Malvern, Pennsylvania) at Washington University. Stimuli were 
projected behind the scanner, visible through a mirror above the eyes. Subjects completed 120 
task trials over the course of 10 bold runs. The various trial types were, to the extent possible, 
evenly interspersed within the 10 runs. Twelve trials occurred in each run. Each trial lasted 35 
seconds (Figure 2.1). Functional images were acquired using a gradient echo echo-planar 
sequence maximally sensitive to BOLD contrast (T2*) (repetition time [TR] = 2000 ms, echo 
time [TE] = 27 ms, field of view [FOV] = 256 mm, flip = 90°, voxel size = 4 mm3). Subjects 
completed a 7.38- minute BOLD run comprised of 210 volumes containing oblique axial images 
(35 slices per volume) which was acquired parallel to the anterior-posterior commissure. 
Structural images were acquired using a sagittal MP-RAGE 3D T1-weighted sequence (TR = 
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2400 ms, TE = 3.16 ms, flip = 8°; voxel size = 1 x 1 x 1 mm). 
Preprocessing included: 1) Slice-time correction, 2) Removal of first 5 images from each 
run to reach steady state, 3) Elimination of odd/even slice intensity differences given 
interpolated acquisition, 4) Rigid body motion correction (Ojemann et al., 1997), 5) Intensity 
normalization to a whole-brain mode value of 1,000 without bias or gain field correction, 6) 
Registration using a 12-parameter affine transform of the structural image to a template image 
in the Talairach coordinate system (Talairach & Tournoux, 1988), 7) Co- registration of fMRI 
volumes to the structural image with 3 mm re-sampling (R. L. Buckner et al., 2004; Ojemann et 
al., 1997), and 8) Smoothing using a 6 mm full-width at half-maximum (FWHM) Gaussian kernel. 
2.4. Quality Control 
 We compared the two groups on movement indices and SNR to determine whether 
there were group differences in these factors that may be influencing group differences in fMRI 
results.  If there were, we confirmed the results of analyses below using subsets of patients and 
controls matched for movement and SNR. We also used techniques discussed by Siegel et al. 
(2013) to remove from GLM estimation volumes in which head motion exceeded a threshold 
(0.5 mm of frame displacement). Participants who lost greater than 40% of the total number of 
frames, or more than 84 of the 210 frames, were excluded from further analysis. 
3. Data Analysis 
3.1. Demographics and Behavioral Data  
 We conducted a Mahalanobis distance analysis on the task variables to identify 
multivariate outlier values, or cases where an individual is responding differently compared to 
other participants across multiple dimensions. Mahalanobis distance was calculated separately 
for patients and control for accuracy (including trial types Maintenance, Resist Distracter, Resist 
Distracter Lure, Update, and Resist Maintenance trials). The probability of distance values were 
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computed separately for patient and control groups. Mahalanobis distance values were 
assessed using χ2 (5, N = 43) = 11.07, p < 0.05), where values with a probability of less than 
0.05 were determined to be outliers and were removed from further analyses.  
 Chi-squared tests were used for categorical variables (gender, ethnicity) to determine if 
these distributions differed between groups. We conducted t-tests on age, education level, 
parental education, symptom scores, and measures of IQ (standard scores of verbal and non-
verbal IQ) to determine if these variables differed between diagnostic groups. Independent 
Mann-Whitney U tests were done for variables that failed to demonstrate variance equality.   
With regard to task data, because we were primarily interested the Update and Resist 
Distracter Lure trials, we conduced at repeated measures ANOVA, with trial type (2 levels; 
Update and Resist Distracter Lure trials) as the within subject factor and diagnosis (2 levels; 
patients and controls) as the between subject factor. We were particularly interested in these 
trials because behavioral accuracy is critically dependent on intact gating functioning. Planned 
contrasts were done when appropriate to determine whether patient performance significantly 
differed from controls. A secondary repeated measures ANOVA was done that included the 
remaining task trials, with trial type (6 levels; Maintenance, Resist Distracter, Resist 
Maintenance, and the 3 novel probe trial types) as the within subject factor and diagnosis (2 
levels; patients and controls) as the between subject factor.  
3.2. fMRI Data Analysis 
3.2.1. Types of GLMS  
We analyzed the fMRI task data in two ways, creating two sets of GLMs. The first set of 
GLMs focused on the 3 events that occurred during the update cue of the trial. We refer to this 
as the “Condition” analysis. For the Condition analysis all trial types were collapsed into three 
events, ignoring the different probe types that could occur within a condition: 1) the update 
condition (Upgreen) in which participants were required to make a update of information, 2) the 
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interference control condition (Upred) in which participants were required to ignore distracters, 
and 3) the maintenance condition (Upempty) in which participants were not presented any 
shape stimuli, and were simply required to maintain the items from the memory set. Analyses at 
the level of Condition could reveal differences between groups when tasked with making an 
update, ignoring distracters, or simply maintain information. A second way we analyzed the 
fMRI task data was to take into account the different probe types within each task condition (i.e. 
breaking the Upred condition into Resist Distracter, Resist Distracter Lure, and Resist Distracter 
Novel Probe trial types). Breaking conditions up allowed us to examine brain activity associated 
with specific errors of interference control, inappropriate updating errors for example (Resist 
Distracter Lure trials), as apposed to a more general error of interference control (i.e. Upred 
Condition trials).  We refer to this as the “trial type” analysis.  For each of these sets of GLMs, 
we estimated task-related activity in each voxel for each subject without assuming a 
hemodynamic response function (HRF) response (Ollinger, Corbetta, & Shulman, 2001). Fifteen 
frames of each trial were estimated for correct and incorrect trials of separately, and the 
resulting beta estimates of event-related responses at each trial time point were entered into 
second-level analyses that treated subjects as a random factor. 
3.2.2. Analysis Approach: Independently Defined ROIs versus Anatomical Mask 
One approach we used to examine the effects of task Condition was to use ROIs 
identified in a previous study of healthy controls using the same task paradigm to assess the 
brain activity as a function of task condition (Ceaser et al., in prep). The results of this study 
revealed patterns of brain activity in response to task conditions that differed between cortical 
and subcortical brain regions. Using these independently defined ROIs allows us to enhance 
statistical power to detect effects by restricting our analysis to only voxels within the previously 
defined regions, but also to attempt to replicate our previous findings and to determine whether 
activity in these regions went on to interact with diagnosis. These regions will be referred to as 
 27 
the independently defined ROIs in the results section. We considered a region to be significant 
for this analyses if p<.05. 
We were also specifically interested in whether regions in the prefrontal cortex and basal 
ganglia, specifically the dorsal striatum, demonstrated condition effects. Thus, as a second 
approach we used anatomical masks of the basal ganglia (Wang et al., 2008) and the prefrontal 
cortex (Rajkowska & Goldman-Rakic, 1995), and examined voxel-wise analyses of brain activity 
within these masks. These ROIs were combined into a single mask (see Appendix A for a 
multislice image of the combined masks) and we used a small volume type I error correction, 
implemented via the Analysis of Functional Neuroimages AlphaSim, of Z > 2.32, k = 20 voxels 
for this combined ROI mask. This analysis could produce regions that show main effects of 
condition and time, and a 2-way interaction of condition by time.  
3.2.3. Replication of Prior Results in Healthy Individuals  
To determine whether we could replicate findings from our previous study in the 
Independently defined ROIs, we examined only the healthy participants in the current study and 
conducted a repeated measures ANOVA at the region level with condition (3 levels; Upgreen, 
Upred, and Upempty) and time (5 levels) as factors. The 5 TRs we used for this analysis 
corresponded to the 5 TR following the presentation of the update cue (frames 8-12, accounting 
for hemodynamic lag). Only correct trials were examined in this analysis. If an ROI 
demonstrated either a significant effect of condition or an interaction of condition and time, we 
then conducted follow-up analyses to determine the source of theses effect, with each analyses 
comparing one condition to another. Separate ANOVAs were done for conditions Upgreen 
versus Upempty and Upred versus Upempty.  
Following the ROI analysis using previously defined regions, next conducted voxel-wise 
analyses within our anatomical masks using only the controls to see if our previous results 
would replicate. Specifically, we conducted voxel-wise repeated measures ANOVA with 
 28 
condition (3 levels; Upgreen, Upred, and Upempty) and time (15 levels) as factors. We included 
all 15 frames of the trial in the analysis to capture regions that show effects of interest, but at 
any time during the course of the trial. We then tested whether or not condition effects occurred 
when we would expect them to during the update component of the trials. For any region 
demonstrating an effect of condition or an interaction of condition and time, we followed up with 
an analysis that focused on 5 frames that occurred after the presentation of the update cues 
and prior to the response of the probe (frames 8-12, accounting for hemodynamic lag). 
Specifically, we conduced a second repeated measures ANOVA at the region level with 
condition (3 levels) and time (5 levels) as factors. We examined the source of any such effect in 
the manner described above, by comparing Upgreen versus Upempty and Upred versus 
Upempty separately.  
Specific Aim 1: Test the hypothesis that individuals with schizophrenia demonstrate 
dysregulated striatal activity during updating and interference control and that striatal 
activity predicts performance deficits. 
3.3. Condition Analysis 
With regard to our first aim, we first examined whether the striatal activity of patients 
displayed different responses to task Condition, updating (Upgreen), interference control 
(Upred) and maintenance (Upempty) demands, when compared with controls. For the 
independently defined ROIs, we conducted a repeated measures ANOVA at the region level 
with condition (3 levels; Upgreen, Upred, and Upempty), diagnosis (2 levels; patients and 
controls), and time (5 levels; frames 8-12) as factors, using only the data from correct trials. 
Because we were only interested in regions that interacted with at least condition and diagnosis, 
we only explored the effects of regions that showed a significant 2-way interaction of condition 
by diagnosis, or a significant 3-way interaction of condition by time by diagnosis.  
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We then conducted voxel-wise analyses within our a priori anatomical masks. This 
analysis involved a repeated measures ANOVA with diagnosis (2 levels), update cue (3 levels), 
and time (15 frames) as factors, treating subjects as a random factor. Given that we were 
specifically interested in regions that interacted with both diagnosis and condition, regions that 
demonstrated either a significant 2-way interaction of diagnosis by condition or a 3-way 
interaction of diagnosis by time by condition were used for further analyses. We also examined 
effects of condition and diagnosis at the whole brain level to uncover brain regions that 
demonstrate interactions of interest that were not within either or ROIs or our anatomical masks. 
We set a whole-brain multiple comparison correction of p < 0.05 using a Z > 3 and a cluster 
sized of at least 21 contiguous voxels (McAvoy, Ollinger, & Buckner, 2001; Ollinger et al., 2001). 
Given that we were primarily interested in effects occurring within our regions of interest we 
have chosen to place results from our whole brain analysis in the Supplemental material section. 
Of note, we recognize that should we find results in regions in our a priori mask and not regions 
outside the mask, we cannot claim specificity to regions inside the mask given the differential 
levels of significance required. However, we felt that this was the best balance between 
providing sufficient power to test a priori hypotheses and being open to unpredicted effects.  
We included all 15 frames in the analyses in the previous step to capture regions that 
show effects of interest, but at any time during the course of the trial. Once these regions were 
identified, we then tested whether condition effects in these regions occurred in response to the 
update events, using a repeated measures ANOVA with diagnosis (2 levels), update cue (3 
levels), and time (5 levels; frames 8-12) as factors, treating subjects as a random factor. Only 
correct trials were used for this analysis. For regions demonstrating significant interactions of 
interest, we explored the interaction in the manner described above examining Upgreen versus 
Upempty and Upred versus Upempty for both diagnostic groups separately. 
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3.4. Trial type Accuracy Analysis 
The second part of Aim 1 involved examining the relationship between brain activity and 
behavioral performance. We predicted that patients with schizophrenia would demonstrate 
dysregulated striatal activity when compared to controls, and this dysregulation would result in 
decreased activity during incorrect trials relative to correct trials when patients are tasked with 
making an information update. In addition, given our predicted relationship between interference 
control, striatal activity, and aberrant salience, we predicted with when patients are tasked with 
ignoring distractors they would demonstrate increased activity during incorrect trials relative to 
correct trials. To test these predictions, we examined activity during the update cue phase for 
specific probe types used in the task (i.e. Update and Resist Distracter Lure) as a function of 
trial accuracy, as opposed to examining the broad update cue conditions (i.e. Upgreen, Upred, 
and Upempty) as a function of accuracy.  
The benefit of examining individual trial types is that we can test predictions about 
specific types of errors. For the Update trial type, an error indicates that the participant rejected 
an item that was presented during a green update cue, suggested that this item was not 
appropriately incorporated into the participant’s active memory set. Looking at this specific type 
of error is more informative than looking at any type of error a participant could make during the 
Upgreen condition, as these could involve failing to identify an item that should have been 
updated, or incorrectly identifying the to-be-replaced item or incorrectly identifying the novel 
probe as correct. In the case of Resist Distracter Lure trials, a correct response indicates that 
participants correctly rejected a response probe that was previously presented as a distracter. If 
a participant makes an error on this trial type, it indicates that the participant incorrectly 
accepted the response probe that was previously presented as a distracter, suggesting that they 
made an inappropriate update. Errors made for the Upred condition, on the other hand, could be 
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the result of an incorrect acceptance of a distracter, but it could also result from participants 
forgetting the original memory set item, or incorrectly identifying a novel probe as correct.  
To test these hypotheses,  we conducted two repeated measures ANOVA (one 
examining Resist Distracter Lure performance and one examining Update performance), with 
accuracy diagnosis as the between subject factor (2 levels, patients and controls) and both 
accuracy (2 levels, correct and incorrect) and timepoint (15 frames) as within subject factors. 
For any significant regions, we conducted a second repeated measures ANOVA for each trial 
type of interest with diagnosis (2 levels), accuracy (2 levels), and time (5 levels; frames 8-12) as 
factors, to determine whether the effects reflected group differences during the update 
component of the trial. We focused our analyses on regions that demonstrated either an 
interaction of diagnosis by accuracy, or the 3-way interaction of diagnosis by time by accuracy.  
Specific Aim 2: Test the hypothesis that in individuals with schizophrenia, 
increased striatal activity during distracter presentation will be positively associated with 
aberrant salience symptoms, delusions, and hallucinations of patients with 
schizophrenia. 
3.5. Relationship between Symptoms and Brain Activity Analysis 
The symptom analysis focused on Magical Ideation, Perceptional Aberration, Social 
Anhedonia, and Physical Anhedonia from the Chapman scales, as well as the total score from 
the ASI. We first sought to replicate the relationships between ASI and other measures of 
psychosis proneness and anhedonia observed previously (Cicero et al., 2010), where strong 
positive correlations between ASI scores, Magical Ideation, and perceptual aberration were 
found. We included measures of anhedonia (Social and Physical) with the expectation that there 
would be little or no correlation between measures of anhedonia and measures of psychosis 
proneness. By including measures of anhedonia we could assess whether the relationships 
between cognition, brain functioning, and symptoms were specific to individual symptom domain 
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(e.g. psychosis proneness) or if they generalized to multiple symptom domains (e.g. psychosis 
proneness and anhedonia). 
To examine the relationship between brain activity and symptom expression we first 
restricted our analysis to regions from the Trial Type Accuracy Analysis that demonstrated 
sensitivity to differences in accuracy during Resist Distracter Lure and Update trials during the 
time period following the presentation of the update cue (frames 8-12). We then extracted the 
average magnitude of activity from the 5 time points of interest for these regions and ran 
Pearson’s correlation analyses between the average of these time points and symptom scores. 
We predicted that patients would display a significant positive correlation between brain activity, 
specifically dorsal striatal activity, associated with the update cue during Distracter Resistance 
Lure trials and ASI, but only when incorrect responses were made to the probe. We did not 
predict a correlation between brain activity associated with Distracter Resistance Lure trials and 
ASI when patients made correct responses to the probe, given that ASI and interference control 
errors are proposed to result from striatal dysregulation and correct trials are not thought to 
result from such dysregulation. That is, striatal activity during incorrect Distracter Lure trials may 
represent instances where dysregulation was sufficient enough to produce false alarms, 
whereas activity during correct trials was not have sufficient to produce false alarms. Further, as 
noted above, we did predict to find significant correlations between ASI and psychosis 
proneness scales (i.e. Magical Ideation and Perceptual Aberration). Thus, if dorsal striatal 
activity is positively associated with aberrant salience, we would also expect to see a positive 
correlation between striatal activity and psychosis proneness scales for patients, but not a 
strong correlation between striatal activity and measures of anhedonia.  
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4. Results 
4.1. Demographics 
 Demographic data for each group is shown in Table 4.1. We did not observe differences 
in gender between groups (χ2 (1) = 1.43, p = 0.23). We conducted T-tests examining differences 
of age, subject education, parental education, and measures of IQ between diagnostic groups. 
We did not find group differences in parental education (t(36) = -1.19, p = 0.34) or subject 
education (t(35) = -0.99, p = 0.9). However, we did find a significant difference of age (t(40) = 
2.49, p = 0.02) between groups, such that the patient group was slightly older than the control 
group (see Table 4.1). We also found a marginal difference in ethnic composition of our groups 
(χ2 (3) = 8.1, p = 0.057, φ = 0.42). Given these differences in age and ethnicity we used these 
variables as covariates during all planned follow up analyses that explored effects that 
interacted with diagnosis from the voxel-wise analyses.  
4.2. Clinical and Cognitive Measures 
 
While controls had numerically higher scores on measures of verbal and non-verbal IQ, 
these differences were not statistically significant (verbal IQ trended towards significance (t(40) 
= -1.85, p = 0.07)). We observed significant differences between the groups on most symptom 
measures, including all Chapman scales (Magical Ideation, Perceptual Aberration, Social 
Anhedonia, and Physical Anhedonia; Table 4.1).1 Interestingly, patients and control scores on  
4.3. Task Performance 
                                            
1 Nonparametric tests were used to compare Perceptual Aberration, Physical Anhedonia, and 
Magical Ideation between groups as these variables failed to demonstrate variance 
homogeneity. 
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Table 4. 1 Demographics, Task Data, and Symptom Scores for Patients and Controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Demographics, cognitive scores, symptom scores, and task data for both patients and controls. P-values of differences between 
groups are listed under the heading “Sig.” Significant p-values are printed in red text. Effect sizes (Cohen’s d) for significant between 
group differences are listed under the heading “ES (d)”. Variables with an asterisk failed tests of equal variances between groups. 
The p-values for these variables were generated using nonparametric tests. 
    SCZ (N=22) Controls (N=20) Sig. ES (d) 
Demographics 
Age 40.41 (8.4) 33.65 (9.19) 0.02 0.77 
Gender  75% Male 55% Male 0.23 
Race 11 AA, 10 Cau 14 AA, 2 Asian, 2 Cau, 1 Other 0.06 0.42 
Subject Education (Years) 15.0 (3.51) 15.1 (2.59) 0.9 
Parental Education (Years) 13.54 (4.74) 14.7 (3.1) 0.34 
Neuropsychological Testing/Questionnaires 
IQ (WAIS III - Vocab) 91.36 (17.33) 100.5 (14.32) 0.07 
IQ (WAIS III - Matrix) 103.86 (14.55) 105.5 (12.24) 0.7 
Aberrant Salience Inventory (ASI)  13.59 (8.29) 9.05 (6.88) 0.06 0.6 
Chapman - Perceptual Aberration* 7.59 (9.23) 2.25 (2.48) 0.03 0.79 
Chapman - Magical Ideation* 11.18 (7.27) 5.10 (4.41) 0.001 1.01 
Chapman - Social Anhedonia 19.64 (9.04) 9.35 (6.02) 0.001 1.34 
Chapman - Physical Anhedonia* 24.41 (12.68) 10.7 (6.37) 0.001 1.37 
Experimental Task 
Resist Distracter 0.63 (0.23) 0.69 (0.19) 0.34 
Resist Distracter Lure* 0.52 (0.26) 0.74 (0.19) 0.006 0.97 
Maintenance* 0.67 (0.22) 0.7 (0.16) 0.46 
Update 0.72 (0.17) 0.82 (0.13) 0.03 0.66 
Resist Maintenance* 0.49 (0.29) 0.69 (0.16) 0.02 0.85 
Resist Distracter Novel Probe 0.60 (0.30) 0.81 (0.25) 0.02 0.76 
Maintenance Novel Probe* 0.64 (0.31) 0.81 (0.21) 0.04          0.64 
  Update Novel Probe* 0.61 (0.32) 0.84 (0.18) 0.02 0.88 
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our measure of aberrant salience (ASI) did not significantly differ from one another, although the 
difference between groups trended towards significance (t(40) = 1.92, p = 0.06, d = 0.6). Task 
performance for the two diagnostic groups can be seen in Figure 4.1. We also examined our 
behavioral data using d’ (the results can be found in Appendix E). Overall, controls performed 
better than patients during the task. Our repeated measures ANOVA of trial type (2 levels, 
Update and Resist Distracter Lure) and diagnosis (2 levels, patients and controls) revealed a 
main effect of diagnosis (F(1,38) = 20.23, p < 0.001), but no main effect of trial type (F(1,38) = 
1.76, p = 0.19), and no interaction of trial type and diagnosis (F(1,38) = 2.7, p = 0.11) when 
using the sphericity correction. Follow up t-tests revealed that performance for both the Update 
trial type (t(38) = -2.47, p = 0.02) and the Resist Distracter Lure trial type (t(38) = -3.35, p = 
0.002) differed between patients and controls, such that patients performed significantly worse 
on both trial types. Given that we found significant differences of novel probe performance 
between diagnostic groups (suggesting a global cognitive deficit rather than one specific to 
distracter resistance, for example) we conducted separate multiple regression analyses to test 
whether diagnostic group could significantly predict Resist Distracter Lure and Update 
performance. We found that diagnostic group trended towards significantly predicting Resist 
Distracter Lure performance when controlling for novel probe performance (B = 0.1, t(41) = 1.88, 
p = 0.07). We did not find that diagnostic group predicted Update accuracy when controlling for 
Update Novel Probe performance, trend or otherwise (B = 0.08, t(41) = 1.33, p = 0.19). A 
repeated measures ANOVA on the remaining trial types revealed a significant main effect of 
diagnosis (F(1,38) = 14, p = 0.001), a trend towards a main effect of trial type (F(2.5,38) = 2.25, 
p = 0.1), and a significant interaction of diagnosis by trial type (F(2.5,38) = 3.11, p = 0.04) when 
using the sphericity correction. Follow up t-tests revealed significant differences between 
diagnostic groups for all trial types, with the exception of Resist Distracter and Maintenance trial 
types (see Table 4.1). For all trial types that demonstrated significant differences between 
diagnostic groups, patients performed worse that controls.  
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4.4. Replication of Prior fMRI Results in Healthy Individuals 
4.4.1. Independently Defined ROI Results  
Examination of brain activity in healthy controls within the independently defined ROIs 
demonstrated either an effect of condition or an interaction of condition by time (Table 4.2) in all 
seven regions. This included bilateral middle frontal gyrus (MFG), left lateral inferior frontal 
gyrus (IFG), right lateral precentral gyrus, left lateral putamen, and right lateral caudate body 
(Table 4.2). Previously we found that these regions demonstrated either effects of condition or 
interactions of condition and time, suggesting these regions were sensitive to task condition. In 
the prior study when examining the pattern of activity in these regions in response to the 
presentation of the update cue, we found that all regions demonstrated significant differences 
between Upgreen and Upempty conditions, suggesting that activity in both cortical and 
subcortical regions demonstrated robust activity to updating demands when compared with 
activity during simple maintenance. Only cortical regions, however, demonstrated either 
significant or trend level differences between Upred and Upempty, suggesting striatal activity 
selectively activated to updating demands when compared with distracter presentation and 
simple maintenance. In the current study, as predicted, Upgreen activity for all cortical regions 
was significantly greater than Upempty activity (with the exception of one region in the 
precentral gyrus, although it trended towards significance). Only one cortical region 
demonstrated a predicted significant difference between Upred and Upempty (IFG, -39, 4, 30; 
Table 4.2 and Figure 4.2A), such that Upred activity was greater than Upempty activity. This 
finding is a replication of our previous study, suggesting that activity in the IFG is sensitive to 
both updating and distracter presentation task demands. Other regions, previously found to 
sensitive to both task demands (i.e. right lateral precentral gyrus and left lateral MFG) did not 
demonstrate the same condition sensitivity in the current sample, suggesting that condition 
sensitivity may be localized to the IFG. Of the striatal regions, the region in the left putamen 
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Figure 4. 1 Task Accuracy for Diagnostic Groups 
 38 
Table 4. 2 Regions from the Previous Data Set and Their Condition Effect in Healthy Controls from the Current Data Set 
X Y Z Size Hemisphere Region BA Effect at frames 8-12 Direction 
              
Analysis of 
Current 
Study 
F p 
Upgreen vs. 
Upempty 
Upred vs. 
Upempty 
Controls, Independently Defined Regions               
Condition Effect in Previous Study 
     
  -43 22 30 27 Left  MFG 9 Cond 6.83 0.003 G > E** no diff 
-39 4 30 25 Left  IFG 9 Cond 12.89 <0.0001 G > E** R > E* 
41 5 33 20 Right  Precentral Gyrus 9 Cond X Time 3.42 0.03 no diff no diff 
Condition X Time in Previous Study 
       -18 -3 13 155 Left  Putamen 
 
Cond 4.72 0.02 G > E* no diff 
13 -10 19 46 Right  Caudate Body 
 
Cond X Time 4.37 0.01 no diff no diff 
-42 17 29 211 Left  MFG 9 Cond 8.84 0.001 G > E** no diff 
42 13 32 79 Right  MFG 9 Cond X Time 3.54 0.02 G > E** no diff 
Independently defined ROIs are listed in the table under the heading “Controls, Independently Defined Regions” and are organized 
based on whether they demonstrated an effect of condition or interaction of condition and time in the previous study. Statistics from 
the update cue response analysis can be found under the heading “Effect at frames 8-12”. Listed under this heading is what analysis 
the independently defined ROIs demonstrated the effect as well as the corresponding F and p values of that effect. In the table, 
under the heading Direction, the pattern and significance of that effect is listed. MFG = Middle Frontal Gyrus and IFG=Inferior Frontal 
Gyrus. G = Upgreen trials, E = Upempty trials, and R = Upred trials. *p<0.05 and **p<0.01. “no diff” signifies no statistically significant 
difference.
 39 
demonstrated significantly greater Upgreen versus Upempty activity, but there was no 
difference between Upred and Upempty (-18, -3, 13; Table 4.2 and Figure 4.2C). Thus, we 
again found that regions within the caudate and putamen demonstrated condition sensitivity to 
Upgreen relative to Upempty and not Upred relative to Upempty. This is consistent with 
theproposed role of the striatum as an information gate, striatal activity activates when the gate 
is open but not when distracters a presented. Further, while a region in the right lateral caudate 
demonstrated a significant interaction of condition and time, neither Upgreen nor Upred activity 
significantly differed from Upempty activity. When examining the time course of this region 
Upempty activity was, unexpectedly, intermediate to that of Upgreen and Upred, which may 
explain why neither condition differed from Upempty. When we examined whether Upred and 
Upgreen significantly differed within this caudate region we found that they did such that 
Upgreen was significantly greater than Upred (F(1,19) = 4.85, p = 0.02). 
4.4.2. Anatomical Mask of Basal Ganglia and Prefrontal Cortex  
We next conducted voxel-wise analyses in our anatomical a priori regions of interest 
using only the data from the healthy controls. Regions demonstrating an effect of condition or an 
interaction of condition by time from healthy control subjects can be found in Table 4.3. One 
region demonstrated a main effect of condition (left MFG, -43, 29, 27), with follow-up analysis 
indicating a highly significant effect of condition during frames 8-12 (F(2,19) = 18.92, p < 0.001; 
Figure 4.3A), such that Upgreen was significantly greater than Upempty but there was no 
difference between Upred and Upempty. There were 5 regions that demonstrated significant 
interactions of condition and time when examining all 15 timepoints, including 3 regions in the 
MFG, bilaterally. Only 2 of them (-42, 24, 23 and 42, 21, 29) demonstrated significant effects of 
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Figure 4. 2 Brain Activity of Healthy Controls and Patients Within Regions Defined in a Previous Data Set 
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Table 4. 3 Regions from the Current Data Set of Healthy Controls that Demonstrated Effects of Condition 
X Y Z Size Hemisphere Region BA Effect at frames 8-12 Direction 
              Analysis F p 
Upgreen vs. 
Upempty 
Upred vs. 
Upempty 
Regions Identified in Current Data Set in Healthy Controls              
Condition 
          -43 29 27 32 Left  MFG 9 Cond 18.92 <0.0001 G > E** no diff 
Condition X Time 
         -12 7 9 36 Left  Caudate Body 
 
Cond X Time 2.99 0.004 G > E** E > R* 
20 -1 9 21 Right  Putamen 
 
Cond X Time 0.56 0.81 
  37 51 3 47 Right  MFG 10 Cond X Time 1.11 0.41 
  -42 24 24 285 Left  MFG 46 Cond X Time 3.02 0.04 G > E* no diff 
42 21 29 262 Right  MFG 9 Cond 8.4 0.001 G > E** no diff 
Regions within our anatomical masks from healthy control in the current data set that demonstrated Condition effects are listed in the 
table under the heading “Regions Identified in the Current Data Set in Healthy Controls”, and are organized on the left side under 
headings like “Diagnosis” or “Condition X Time” based on whether they demonstrated these effects when examining all 15 time 
frames of the trial. Listed under the heading “Effect at frames 8-12” is in what analysis the independently defined ROIs demonstrated 
an effect as well as the corresponding F and p values of that effect. In the table, under the heading Direction, the pattern and 
significance of that effect is listed. MFG = Middle Frontal Gyrus. G = Upgreen trials, E = Upempty trials, and R = Upred trials. *p<0.05 
and **p<0.01. “no diff” signifies no statistically significant difference.
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Figure 4. 3 Regions of Healthy Controls from the Current Data Set that Demonstrated 
Effects of Condition 
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condition or condition by time in response to the update cue (Table 4.3). For both of these 
regions, Upgreen activity was significantly greater than Upempty, but neither showed 
differences between Upred and Upempty activity. While there were two regions in the dorsal 
striatum that demonstrated interactions of condition and time when examining all 15 frames of 
the trial, only a region in the caudate (-12, 7, 9) continued to demonstrated a significant 
interaction of condition and time in analyses restricted to the time periods associated with the 
update cue (F(2,19) = 2.99, p = 0.004; Table 4.3). For this region Upgreen activity was 
significantly greater than Upempty activity, and there was a significant difference between 
Upred and Upempty, such that, unexpectedly, Upempty activity was significantly greater than 
Upred activity (Figure 4.3B). Thus, a number of the regions identified in a previous study 
demonstrated predicted differences between Upgreen and the comparison condition, Upempty, 
such that Upgreen activity was greater than Upempty. Only one region in the IFG demonstrated 
a predicted difference between Upred and Upempty. 
Specific Aim 1: Test the hypothesis that individuals with schizophrenia demonstrate 
dysregulated striatal activity during updating and interference control and that striatal 
activity predicts performance deficits. 
4.5. Condition Results 
4.5.1. Independently Defined ROIs  
We started by examining whether activity in the independently defined ROIs differed as 
a function of diagnostic group.  Results from this analysis can be found in Table 4.4. We found 
that activity within 2 regions demonstrated a significant interaction of diagnosis and condition, 
including a region in the left IFG (-39, 4, 30) and a region in the left MFG (-42, 17, 29).  For the 
IFG, activity during the Upgreen condition was significantly greater than activity during Upempty 
for both patients and controls (Figure 4.2A and 4.2B). Controls demonstrated significantly 
greater Upred than Upempty activity (there was a trend towards greater Upred versus Upempty 
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Table 4. 4 Regions from a Previous Data Set and Their Diagnosis by Condition Effects for Patients and Controls from the 
Current Data Set 
X Y Z Size Hemi Region BA Diagnosis Interaction Direction (Patients) Direction (Controls) 
              
Analysis F p 
Upgreen vs. 
Upempty 
Upred vs. 
Upempty 
Upgreen vs. 
Upempty 
Upred vs. 
Upempty 
Condition 
        
    -43 22 30 27 Left  MFG 9 Dx X Cond 2.55 0.09 
    -39 4 30 25 Left  IFG 9 Dx X Cond 3.76 0.03 G > E** no diff G > E** R > E* 
41 5 33 20 Right  Precentral Gyrus 9 Dx X Cond 0.56 0.57 
    Condition X Time 
           -18 -3 13 155 Left  Putamen 
 
Dx X Cond 1.51 0.28 
    13 -10 19 46 Right  Caudate Body 
 
3-way 2.08 0.03 no diff no diff no diff no diff 
-42 17 29 211 Left  MFG 9 Dx X Cond 3.54 0.02 no diff R > E* G > E** no diff 
42 13 32 79 Right  MFG 9 Dx X Cond 2.54 0.09         
Statistics for independently defined regions that demonstrated diagnosis by Condition effects. We only conducted follow up analyses 
for the update cue period on regions that demonstrated a significant effect of condition or a significant interaction of condition and 
time. Statistics from the update cue response analysis can be found under the heading “Effect at frames 8-12”. The direction of 
Upgreen and Upred versus Upempty effects for controls found in the previous analysis (Table 4.2) are listed to the right of the 
direction of effects for patients to ease comparison between the two groups within this table. G = Upgreen trials, E = Upempty trials, 
and R = Upred trials. *p<0.05 and **p<0.01. “no diff” signifies no statistically significant difference. 
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for patients, p = 0.095). When we compared Upgreen activity for the IFG (-39, 4, 30) between 
groups we found a trend towards significantly greater for controls than it was for patients 
(F(1,41) = 3.13, p = 0.09), but no difference between groups for Upred activity (F(1,41) = 0.18, p 
= 0.67).The other region that demonstrated a diagnosis by condition interaction was a region in 
the left MFG. In this region controls demonstrated significantly greater Upgreen than Upempty 
activity and this difference trended towards significance for patients (p = 0.07). Interestingly, 
within this region, patients, but not controls showed greater Upred than Upempty activity. When 
we compared Upgreen activity for the MFG (-42, 17, 29) between groups we found that activity 
was significantly greater for controls than it was for patients (F(1,41) = 4.52, p = 0.04), but no 
difference between groups for Upred activity (F(1,41) = 0.52, p = 0.47). 
A region in the right caudate body (13, -10, 19) demonstrated a 3-way interaction of 
diagnosis by time by condition (Table 4.4). However, when comparing Upgreen versus Upempty 
and Upred versus Upempty during the frames following the update cue, neither diagnostic group 
demonstrated a significant difference between conditions. As mentioned above, examining the 
time course for this region revealed an unexpected increase of Upempty activity, such that it 
activity was intermediate to Upgreen and Upred for controls. This was not also the case for 
patients. Generally, putamen activity for patients was numerically lower than controls and did 
not appear to respond to trial events (i.e. the memory set and update cue) that way that control 
putamen activity did. The elevated Upempty activity and Upgreen activity for controls may 
explain why we observed a significant interaction of diagnosis by condition for this region whilst 
failing to observe differences between the comparison condition and Upgreen/Upred. However, 
when we compared caudate activity between diagnostic groups during Upgreen and Upred 
conditions we found that while controls had numerically higher Upgreen and Upred activity, 
these differences were not significant (F(1,41) = 2.19, p = 0.15 and F(1,41) = 1.26, p = 0.27, 
respectively). 
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Table 4. 5 Regions from the Current Data Set that Demonstrated Diagnosis by Condition Effects Within our Anatomical Masks 
X Y Z Size Hemisphere Region BA 
Diagnosis 
-23 -10 4 149 Left  Globus Pallidus 
24 -11 5 126 Right  Globus Pallidus 
24 -11 5 126 Right  Globus Pallidus 
16 -1 19 34 Right  Caudate Body 
16 -1 19 34 Right  Caudate Body 
-40 38 7 282 Left  IFG 46 
29 53 2 57 Right  MFG 10 
-36 20 23 33 Left  MFG 9 
40 9 30 65 Right  IFG 9 
30 30 28 30 Right  MFG 9 
-40 8 33 31 Left  
Precentral 
Gyrus 9 
Condition 
-42 4 31 22 Left  IFG 9 
Condition X Time 
-19 0 8 243 Left  Putamen 
17 3 10 152 Right  Putamen 
36 52 5 40 Right  MFG 10 
-41 23 25 390 Left  MFG 46 
42 20 29 265 Right  MFG 9 
-28 34 33 21 Left  SFG 9 
Diagnosis X Time 
-24 -4 2 53 Left  Putamen 
-16 -5 20 24 Left  Caudate Body 
15 -6 21 35 Right  Caudate Body 
-39 5 31 39 Left  IFG 9 
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28 31 -5 37 Right  IFG 47 
-39 43 6 190 Left  MFG 46 
-39 34 25 44 Left  MFG 46 
46 22 26 63 Right  MFG 46 
35 6 32 22 Right  
Precentral 
Gyrus 9 
Regions within our anatomical masks from the current data set that demonstrated diagnosis by Condition effects within our 
anatomical masks. They are organized on the left side under headings like “Diagnosis” or “Condition X Time” based on whether they 
demonstrated these effects when examining all 15 time frames of the trial. We only conducted follow up analyses for the update cue 
period on regions that demonstrated a significant interaction of condition and diagnosis. Statistics from the update cue response 
analysis can be found under the heading “Effect at frames 8-12”. G = Upgreen trials, E = Upempty trials, and R = Upred trials. 
*p<0.05 and **p<0.01. “no diff” signifies no statistically significant difference.
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4.5.2. Anatomical Mask of Basal Ganglia and Prefrontal Cortex  
Regions from our a priori anatomical mask analysis that demonstrated either a main 
effects of task condition, time, and diagnosis, or interactions are listed in Table 4.5. We focused 
our analysis on regions that demonstrated either an interaction of diagnosis by condition or 
Diagnosis by time by condition. Results from the whole brain analysis can be found in Appendix 
B. Only one region demonstrated a condition X diagnosis interaction: left lateral MFG (-41, 30, 
26; not in Table 4.5), an interaction that held when examining only the 5 frames following the 
update cue (F(2,41) = 6.4, p = 0.004). The pattern of activity within this region was that only 
controls demonstrated significant greater activity during Upgreen versus Upempty (Table 4.5, 
Figure 4.4), with no significant difference between Upred and Upempty. When we compared 
differences of Upgreen and Upred activity within this region between groups we found that 
controls has significantly greater activity during Upgreen relative to patients (F(1,41) = 4.53, p = 
0.04) but there was no difference between Upred activity (F(1,41) = 0.7, p = 0.41). 
4.6. Trial type Accuracy Results 
4.6.1. Anatomical Mask of Basal Ganglia and Prefrontal Cortex  
We conducted a repeated measures ANOVA for each trial type with accuracy (correct and 
incorrect trials) and time (all 15 time points of the trial) as a within subjects factors, and 
diagnostic group (patients and controls) as the between subjects factor, separately for Update 
and Resist Distractor Lures. We did not examine trial type effects within the independently 
defined regions because those regions were defined by examining Condition effects (e.g. 
Upgreen). We could not examine the effect of trial type accuracy in the previous sample due to 
lack of behavioral variability (many participants from the previous study made few errors, if any). 
Further, these independently defined regions were identified examining differences between 
conditions during only correct trials. Thus, it was unclear whether they would demonstrate 
effects of accuracy. Given that we were primarily interested in regions that interacted with 
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Figure 4. 4 Frontal Region from the Current Data Set that Demonstrated a Diagnosis by Condition Interaction 
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diagnosis we focused our analyses on regions that demonstrated either an interaction of 
diagnosis by accuracy or diagnosis by time by accuracy. Regions that demonstrated relevant 
effects from our whole brain analysis can be seen in the Appendix C and D.  
We first focused on the Resist Distracter Lure trial type (Table 4.6). During this trial type 
participants are presented with a distracter during the update cue, which they are instructed to 
ignore. During the probe, however, they are presented with the item they were instructed to 
ignore. Correct trials indicate a correct rejection of the probe and incorrect trials suggest they 
inappropriately encoded the distracter. Two regions demonstrated and interaction of accuracy 
and diagnosis, including the right lateral putamen (23, 0, 4) and right lateral MFG (40, 13, 30) 
when examining all 15 frames of the trial. When examining whether these regions demonstrated 
this effect following the presentation of the update cue (in this case, the presentation of a 
distracter) we found that both regions still demonstrated a significant interaction of diagnosis 
and accuracy (Table 4.6). For patients, activity during incorrect trials (where, at the probe, the 
identified the distracter presented during the update cue as a correct response) was significantly 
greater than trials when they correctly rejected the distracter at the probe. This was true for both 
the putamen (Figure 4.5A) and the MFG (Figure 4.5C). Controls, however, did not show this 
pattern. If anything, for controls correct trial activity within a region in the putamen trended 
towards being significantly greater than incorrect trial activity following the update cue (Figure 
4.5B), which is the opposite of the pattern observed for patients in this region. The same was 
true of controls for activity in the MFG, where correct trial activity was numerically greater than 
incorrect trial activity (Figure 4.5D). 
 Next we examined the Update trial type. Here participants are presented with a new 
shape during the update cue and are signaled to remember the new shape in place of one of 
the original items in the memory set. At the probe they are presented with one of the update 
items presented at the update cue, to which they would respond “yes”. Correct responses 
 51 
Table 4. 6 Regions Demonstrating an Effect of Diagnosis by Resist Distracter Lure Trial Type Accuracy within our 
Anatomical Masks 
X Y Z Size Hemi Region BA Effect at frames 8-12 Correct vs. Incorrect 
       
Analysis F p Patients Controls 
Diagnosis 
          -25 -18 -1 44 Left  Putamen 
      -39 35 2 45 Left  IFG 46 
     23 51 6 21 Right  SFG 10 
     -33 48 13 22 Left  MFG 10 
     -33 7 33 25 Left  Precentral Gyrus 9 
     Accuracy 
          25 55 3 21 Right  SFG 10 
     Accuracy X Time 
         23 -14 7 35 Right  Putamen 
      Diagnosis X Accuracy 
         23 0 4 44 Right  Putamen 
 
Dx X Acc 10.41 0.003 cor < incor** cor > incor** 
40 13 30 70 Right  MFG 9 Dx X Acc 14.7 <0.0001 cor < incor** no diff 
Regions from the current data set that demonstrated diagnosis by Resist Update Lure accuracy. They are organized on the left side 
under headings like “Diagnosis” or “Accuracy” based on whether they demonstrated these effects when examining all 15 time frames 
of the trial. We only conducted follow up analyses for the update cue period on regions that demonstrated a significant interaction of 
accuracy and diagnosis. Statistics from the update cue response analysis can be found under the heading “Effect at frames 8-12”. 
“cor” = correct trials and “incor” = incorrect trials. *p<0.05 and **p<0.01. “no diff” signifies no statistically significant difference.
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Figure 4. 5 Regions Demonstrating a Diagnosis by Resist Distracter Lure Trial Type Accuracy Interaction 
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suggest that information was appropriately remembered, and incorrect responses suggest that 
participants did not update the item as instructed. We again focused our analyses on regions 
that interacted with at least both diagnosis and accuracy.  
When examining all 15 time frames there were 2 regions that demonstrated an 
interaction of diagnosis and accuracy (bilateral globus pallidus, -21, -7, 0 and 25, -17, 0) and 2 
regions that demonstrated a 3-way interaction of diagnosis by time by accuracy (bilateral IFG, 
including 40, 43, 1 and -42, 8, 31). When examining whether these regions continued to interact 
with diagnosis and accuracy in analyses restricted to the frames following the presentation of 
the update cue (frames 8-12) we found that two regions from bilateral globus pallidus and one 
region in the IFG demonstrated significant interactions of diagnosis by accuracy (Table 4.7). For 
patients, activity in both regions of the globus pallidus significantly differed when comparing 
correct and incorrect Update activity following the presentation of the update cue, such that 
correct activity was greater than incorrect activity (Figure 4.6A and 4.6C). For controls, correct 
and incorrect activity in these regions also significantly differed from one another, however 
incorrect trial activity in both regions was greater than correct trial activity. The pattern for 
controls when comparing correct Update trial activity to incorrect Update trial activity was the 
opposite of the pattern of correct versus incorrect Update trial activity for patients (Figure 4.6B 
and 4.6D). We did not expect to find that healthy controls demonstrate and opposite pattern of 
effects relative to patients when looking at correct and incorrect trial performance. One possible 
explanation for this may be related to differences in the proportion of correct and incorrect trials 
available for analysis between groups. Controls made significantly fewer errors on both Resist 
Distracter Lure and Update trials, which could results in more variable averaged time courses 
for incorrect trials. This interpretation makes some sense, particularly when visually inspecting 
the time course of putamen activity for controls during incorrect Resist Distract Lure trials 
(Figure 4.5 B).  
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Another region, right lateral IFG, also demonstrated a significant effect of diagnosis by 
accuracy following the presentation of the update cue, but when comparing correct and 
incorrect Update trial activity within diagnostic groups neither group demonstrated a difference 
(Table 4.7). We examined the time course of activity for this region to determine where the 
effect was coming from. While numerically the pattern of activity in this region was the same for 
patients and controls as what we observed in the globus pallidus (greater correct than incorrect 
trial activity following the presentation of the update cue for patients and the opposite pattern for 
controls), the differences did not reach significance. There did appear to be differences earlier 
during the trial (around the onset of the memory set) for both patients and controls that may 
have driven the initial interaction of diagnosis by time by accuracy when we examined all 15 
time frames. 
 For our first aim we found evidence to suggest that patients with schizophrenia 
demonstrated deficits of updating and interference control and that, at least for interference 
control, there was a trend to suggest that this deficit of behavioral performance for patients was 
not due to a general deficit of distracter resistance. That while both cortical and subcortical 
activity for controls generally demonstrated condition sensitivity, for patients condition sensitivity 
was reduced, particularly within the striatum. We also found that evidence to support our 
hypothesis that dysregulated striatal activity was associated with interference control 
performance deficits for patients, given that striatal activity during incorrect trials was greater 
than correct trial activity. However, contrary to our predictions, we found that for patients a 
region in the cortex also demonstrated greater incorrect relative to correct interference control 
trial activity. Further, controls demonstrated the opposite pattern of activity relative to patients 
when comparing correct and incorrect trial activity, which was not expected. 
Specific Aim 2: Test the hypothesis that in individuals with schizophrenia, increased 
striatal activity during distracter presentation will be positively associated with aberrant 
salience symptoms, delusions, and hallucinations. 
 55 
Table 4. 7 Regions Demonstrating an Effect of Diagnosis by Update Trial Type Accuracy within our Anatomical Masks 
X  Y  Z  Size Hemisphere Region BA Effect at frames 8-12 Correct vs. Incorrect 
              Analysis F p Patients Controls 
Diagnosis 
          
24 -9 4 222 Right  Putamen 
 
     
14 3 15 92 Right  Caudate Body 
 
     
-22 -8 5 251 Left  Globus Pallidus 
 
     
-40 38 7 211 Left  IFG 46 
     
30 30 -5 40 Right  IFG 47 
     
23 52 3 23 Right  SFG 10 
     
39 18 28 133 Right  MFG 9 
     
-39 8 34 
42 
Left  
Precentral 
Gyrus 9      
Accuracy 
 
 
   
     
-36 8 29 34 Left  IFG 9 
     
44 8 32 38 Right  MFG 9 
     
Accuracy X Time 
 
   
     
11 -1 14 27 Right Caudate Body 
 
     
35 34 -5 28 Right MFG 47 
     
37 28 29 87 Right MFG 9 
     
-44 11 29 64 Left IFG 9 
     
Diagnosis X Time 
 
   
     
44 40 -2 49 Right  Sub-Gyral 10 
     
-40 44 3 180 Left  IFG 10 
     
42 18 30 91 Right  MFG 9 
     
Diagnosis X Accuracy 
        -21 -7 0 34 Left  Globus Pallidus 
 
Dx X Acc 9.49 0.004 cor > incor* cor < incor** 
25 -17 0 34 Right  Globus Pallidus 
 
Dx X Acc 13.99 0.001 cor > incor** no diff 
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Diagnosis X Time X Accuracy 
       40 43 1 41 Right  IFG 10 Dx X Acc 4.53 0.04 no diff no diff 
-42 8 31 24 Left  IFG 9 Dx X Acc 0.01 0.92     
Regions from the current data set that demonstrated diagnosis by Update accuracy. They are organized on the left side under 
headings like “Diagnosis” or “Accuracy” based on whether they demonstrated these effects when examining all 15 time frames of the 
trial. We only conducted follow up analyses for the update cue period on regions that demonstrated a significant interaction of 
accuracy and diagnosis. Statistics from the update cue response analysis can be found under the heading “Effect at frames 8-12”. 
“cor” = correct trials and “incor” = incorrect trials. *p<0.05 and **p<0.01. “no diff” signifies no statistically significant difference.
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Figure 4. 6 Regions Demonstrating a Diagnosis by Update Trial Type Accuracy Interaction 
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4.8. Relationship between Symptoms and Brain Activity Results 
 
For our second aim we sought to examine the relationship between brain activity, 
specifically striatal activity, and aberrant salience for patients with schizophrenia. We first 
assessed the relationship between ASI scores and measures of psychosis proneness and 
anhedonia from the chapman scales. For patients (Table 4.8, burgundy text) we found that ASI 
scores were, as expected, positively correlated with perceptual aberration magical ideation.  
However, contrary to expectation, ASI scores were also positively correlated with measures of 
physical anhedonia and social anhedonia. For controls, we found that ASI was only significantly 
correlated with magical ideation (Table 4.8, green text). All correlations between ASI and 
measures from the Chapman scales were positive for controls. 
With regard to the relationship between brain activity of patients during correct and incorrect 
Resist Distracter Lure trials, we conducted a correlational analysis examining the relationship 
between brain activity of regions demonstrating an effect of accuracy by diagnosis (putamen 
and MFG, see above) during Distracter Lure trials and symptom expression scores. Because 
we predicted that the susceptibility to distracter presentation would be associated with aberrant 
salience, we examined brain activity during both correct and incorrect trials.  
For patients (burgundy text), aberrant salience did not significantly correlate with 
putamen activity in response to the update cue when patients made correct responses. Correct 
trial putamen activity of patients significantly positively correlated with only one other measure of 
psychosis proneness – magical ideation. Incorrect trial activity in the putamen of patients 
following the presentation of the update cue did positively correlate with aberrant salience 
(Table 4.8 and Figure 4.7), and this correlation was significant. Incorrect trial activity in the 
putamen of patients also demonstrated a significant positive correlation with magical ideation. 
We tested whether the correlation between ASI and putamen activity for correct versus incorrect 
trials differed for patients (Meng, Rosenthal, & Rubin, 1992), and we found a trend towards 
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Table 4. 8 Correlations Between Correct and Incorrect Resist Distracter Lure Trial Type Brain Activity and Aberrant Salience, 
Psychosis Proneness, and Anhedonia Measures 
  
ASI PR PA SA  MI 
Putamen 
(correct) 
Putamen 
(incorrect) 
MFG 
(correct) 
MFG 
(incorrect) 
ASI 
 
0.20 0.11 0.38 0.72** -0.38 -0.32 0.20 -0.24 
PR 0.69** 
 
0.26 0.67** 0.51* -0.34 -0.49* -0.35 -0.71** 
PA 0.48* 0.49* 
 
0.74** 0.09 0.03 -0.24 -0.43 -0.59** 
SA  0.54** 0.7** 0.63** 
 
0.39 -0.22 -0.6** -0.39 -0.76** 
MI 0.73** 0.87** 0.56** 0.77** 
 
-0.47* -0.41 0.21 -0.44 
Putamen 
(correct) 
0.19 0.40 0.19 0.33 0.45* 
 
0.53* -0.27 0.25 
Putamen 
(incorrect) 
0.56** 0.34 0.32 0.23 0.43* 0.33 
 
-0.11 0.6** 
MFG 
(correct) 
-0.33 -0.33 -0.38 -0.27 -0.34 0.22 -0.32 
 
0.44 
MFG 
(incorrect) 
0.37 0.26 -0.16 0.11 0.22 0.03 0.22 0.34   
Correlations between Resist Distracter Lure, correct and incorrect, trial brain activity and clinical symptom measures. Patient 
correlations are printed in burgundy and controls correlations are printed in green. ASI = aberrant salience inventory. PR = 
perceptual aberration. PA = physical anhedonia. SA = social anhedonia. MI = magical ideation. *p<0.05 (2-tailed) and **p<0.01 (2-
tailed).
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significance (z=-1.56, p = 0.06). Correct activity in the MFG negatively correlated with ASI 
scores, but this correlation did not reach significance. The direction of the correlation between 
correct MFG activity and other measures of psychosis proneness, including perceptual 
aberration and magical ideation, was also negative but these correlations also did not reach 
significance. We were interested in determining whether the correlation between incorrect trial 
activity and ASI differed between he putamen and MFG, and found that the correlations did not 
significantly differ (z=0.8, p = 0.21). 
For controls (Table 4.8, green text), we found no correlation between ASI scores and 
either correct or incorrect activity for the putamen and MFG (Table 4.8). Incorrect Resist 
Distracter Lure activity in the putamen was negatively correlated with perceptual aberration and 
social anhedonia, but did not significantly correlate with any other measure of psychosis 
proneness or anhedonia. We found that, when comparing the correlation between putamen 
activity and social anhedonia, correlations for correct trial and incorrect trial activity significantly 
differed from one another (z=-1.83, p = 0.03). However, we did not find that the correlation 
between correct trial putamen activity and perceptual aberration differed from the correlation 
between incorrect trial putamen activity and perceptual aberration (z=-0.72, p = 0.24), nor did 
the correlation between correct trial putamen activity and magical ideation differ from the 
correlation between incorrect trial putamen activity and magical ideation (z=-0.29, p = 0.39). For 
the MFG, while correct activity did not significantly correlate with any measure of psychosis 
proneness or anhedonia, incorrect trial activity demonstrated significant negative correlations 
with perceptual aberration, physical anhedonia, and social anhedonia. The correlation between 
MFG activity and perceptual aberration significantly differed between correct and incorrect trials 
(z=-1.8, p = 0.04) as did the correlation between MFG activity and social anhedonia when 
comparing correct and incorrect trial activity (z=-1.98, p = 0.02), but correlations between MFG 
activity and physical anhedonia did not differ when comparing correct and incorrect trials (z=-
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0.77, p = 0.2). Incorrect trial activity in the MFG for controls was not significantly correlated with 
ASI (Figure 4.7) or magical ideation, although the direction of the correlations for these variables 
was also negative. Finally, we examined whether the significant correlation between ASI and 
incorrect trial putamen activity significantly differed between patients and controls. We found 
that, indeed, it did (z=2.89, p = 0.004).  
Next we examined the relationship between aberrant salience and brain activity in 
regions from the trial type analysis (see above) that demonstrated a significant interaction of 
diagnosis and Update accuracy. We found that two regions, bilateral globus pallidus (Table 4.7), 
during the Update trial demonstrated a significant interaction of diagnosis by accuracy in 
response to the update cue. For both of these regions patients demonstrated a significant 
positive correlation between ASI scores and brain activity, but only during correct trials (Table 
4.9 and Figure 4.8). The correlation between ASI and incorrect trial activity significantly differed 
from the correlation between ASI and correct trial activity for both left (Z= 2.26, p = 0.01) and 
right (Z = 2.84, p = 0.002) lateral globus pallidus. Left lateral globus pallidus activity also 
significantly correlated with magical ideation in the same direction, but not with perceptual 
aberration or the anhedonia measures. Right lateral globus pallidus activity, however, 
demonstrated significant positive correlations with all other measures of psychosis proneness 
and anhedonia.  
For controls, we observed a significant negative correlation between ASI and right lateral 
globus pallidus activity during incorrect Update trials. Activity in this region did not significantly 
correlate with other measures of psychosis proneness or anhedonia. When we compared the 
correlation between ASI and right lateral globus pallidus activity during incorrect and correct 
trials we found that no difference between correlations (z=-1.14, p = 0.13). While correct trial 
activity in bilateral globus pallidus did not significantly correlate with ASI, we did observe 
significant negative correlations with magical ideation (Table 4.9) bilaterally. Neither correlation  
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Figure 4. 7 Scatter Plots Depicting the Relationship Between ASI and Brain Activity During Correct Resist Distracter Lure 
Trials 
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between left and right globus pallidus correct trial activity and magical ideation significantly 
differed from respective incorrect trial correlations between brain activity and magical ideation. 
 For our second aim we predicted that increased activity during striatal activity during 
distracter presentation would be positively associated with positive symptoms expression,   
particularly with ASI. We found that while correct trial activity of the putamen or MFG did not 
significantly correlate with symptom expression incorrect trial activity did, but only for the 
putamen and not the MFG. Further, this was true for patients but not controls. This finding was 
consistent with the predicted relationship between interference control deficits for patients, 
striatal dysregulation, and symptom expression. We also found that for patients increased 
globus pallidus activity during correct Update trials was associated with ASI, which is consistent 
with the idea that greater activity in the basal ganglia is associated with aberrant salience. While 
we would predict that regions within the globus pallidus demonstrate increased activity other 
regions (regions within the external capsule) would not. Given its size, it is difficult to say where 
the regions demonstrating effects of interest in our study fall within the globus pallidus. 
5. Discussion 
This study first sought to test whether individuals with schizophrenia have dysregulated 
striatal activity when processing cognitive control demands, whether this dysregulation is 
associated with performance deficits, and whether striatal activity is associated with aberrant 
salience symptoms. The current study was motivated by previous work that proposed a role for 
the dorsal striatum as a mechanism of gating during cognitive control (Hazy et al., 2006; Miller, 
2013), the putative dependence of this mechanism on dopamine signaling, and evidence of 
dysregulated dopamine signaling in the associative striatum for patients with schizophrenia 
(Howes et al., 2012; Kegeles et al., 2010). Thus, we first predicted that the brain activity of 
patients, particularly in the dorsal striatum, would differ from controls during updating and 
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interference control performance. Using a novel task that separately examined updating, 
interference control, and simple maintenance, we found evidence suggesting that both 
prefrontal and striatal activity differed between patients and controls during the execution of task 
demands. Overall, patients demonstrated a decreased magnitude of prefrontal activity in 
response to updating demands when compared with controls, and, unlike controls, patients did 
not show differences in activation between updating and interference control relative to simple 
maintenance in the striatum. We found some evidence for altered caudate activity during task 
processing, though the pattern was not as clear as that for prefrontal cortex. When examining 
differences of brain activity between diagnostic groups during correct and incorrect updating and 
predicted that dysregulated striatal activity would be associated with aberrant symptom 
expression for patients. We found that, indeed, striatal activity was associated with aberrant 
salience symptom expression for patients but not controls and the correlation between striatal 
activity and aberrant salience significantly differed between diagnostic groups. Interestingly, 
although both prefrontal cortical activity and striatal activity of patients with schizophrenia 
demonstrated similar patterns of activity in response to cognitive control demands, only striatal 
activity was significantly correlated with aberrant salience symptom expression. Each of these 
findings will be discussed in more detail below.  However, first we will discuss the results of our 
replication analyses in just the healthy controls. 
5.1. Replication of Prior fMRI Results in Healthy Individuals: 
5.1.1. Independently Defined ROI  
Previously we found that cortical activity increased during both information updating 
events and distracter presentation compared to a basic maintenance condition, but that activity 
within the dorsal striatum selectively activated to information updating and not interference 
control (Ceaser et al., in prep). Further, we found that during the presentation of the update cue, 
only brain activity within an anatomical mask of the basal ganglia, and not the prefrontal or 
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Table 4. 9 Correlations Between Correct and Incorrect Update Trial Type Brain Activity and Aberant Salience, Psychosis 
Proneness, and Anhedonia Measures 
  
ASI PR PA SA  MI 
L Globus 
Pallidus 
(correct) 
L Globus 
Pallidus 
(incorrect) 
R Globus 
Pallidus 
(correct) 
R Globus 
Pallidus 
(incorrect) 
ASI   0.20 0.11 0.38 0.72** -0.11 -0.24 -0.31 -0.59* 
PR 0.69** 
 
0.26 0.67** 0.51* -0.05 0.16 -0.31 0.26 
PA 0.48* 0.49* 
 
0.74** 0.09 0.11 0.32 -0.03 0.30 
SA  0.54** 0.7** 0.63** 
 
0.39 0.03 0.22 -0.22 0.21 
MI 0.73** 0.87** 0.56** 0.77** 
 
-0.48* -0.43 -0.59* -0.38 
L Globus 
Pallidus 
(correct) 
0.58** 0.37 0.37 0.31 0.51* 
 
0.65** 0.65** 0.17 
L Globus 
Pallidus 
(incorrect) 
0.15 0.21 0.24 0.17 0.29 0.58** 
 
0.52* 0.42 
R Globus 
Pallidus 
(correct) 
0.64** 0.54* 0.52* 0.6** 0.65** 0.86** 0.41 
 
0.27 
R Globus 
Pallidus 
(incorrect) 
-0.16 0.12 0.21 0.10 -0.06 0.08 0.51* 0.11   
Correlations between Update, correct and incorrect, trial brain activity and clinical symptom measures. Patient correlations are 
printed in burgundy and controls correlations are printed in green. ASI = aberrant salience inventory. PR = perceptual aberration. PA 
= physical anhedonia. SA = social anhedonia. MI = magical ideation. *p<0.05 and **p<0.01. 
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Figure 4. 8 Scatter Plots Depicting the Relationship Between ASI and Brain Activity During Incorrect Update Trials 
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parietal cortices, could significantly predicted whether an individual made a correct or incorrect 
response at the probe. These results provided some support for the idea that the basal ganglia 
may function as a mechanism of information gating during cognitive control, and were 
consistent with previous studies examining subcortical contributions to cognitive control. For 
example, a lesion study of stroke patients found that lesions of the left lateral putamen and 
surrounding white matter resulted in deficits of distracter resistance (Baier et al., 2010), 
suggesting that the basal ganglia may play an important role in gating relevant information. 
Similarly, McNab et al. (McNab & Klingberg, 2008) found that the globus pallidus demonstrated 
selective associations with filtering unnecessary storage activity, suggesting that increases of 
globus pallidus activity may serve to filter our distracters from entering working memory storage. 
Other studies have shown that the dorsal striatum is involved in selective updating (Murty et al., 
2011; Roth et al., 2006) and working memory manipulation (Lewis, Dove, Robbins, Barker, & 
Owen, 2004) when compared with other cognitive control processes. A study of dopamine 
depletion in the caudate of marmoset monkeys demonstrated the importance of dopamine when 
executing these cognitive processes, as the monkeys demonstrated selective deficits of a 
delayed response task but preserved attentional set-shifting (Collins, Wilkinson, Everitt, 
Robbins, & Roberts, 2000), although dopamine depletion influencing updating may not be the 
only explanation of these results. 
Using the regions from our previous study we examined whether healthy controls from 
our current data set demonstrated the same pattern of condition effects. We again found that 
healthy control participants demonstrated greater prefrontal and striatal activity during updating 
than simple maintenance conditions. We also found some evidence that prefrontal activity in 
these independently defined regions demonstrated some transient activity to distracter 
presentation, consistent with our previous findings, though not all of the prefrontal regions 
demonstrated this effect. We did not find a significant response to distracter presentation within 
any of the striatal regions. These findings are partially consistent with the findings from our 
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previous study, and suggest that while both the cortex and striatum process updating demands, 
the striatum may selectively activate and the PFC, particularly the IFG, may demonstrate more 
general condition sensitivity. For one of the independently defined striatal regions (right lateral 
caudate) we found maintenance activity that was intermediate to interference control and 
update activity. This was unexpected, given that participants were not presented with any 
shapes during the maintenance condition and maintenance activity that was greater than 
interference control activity was not something we found during our previous study. Because we 
used maintenance trials as our comparison condition increased activity during this condition 
may explain why we did not find differences between maintenance and updating or interference 
control. This finding is discussed in more detail below. 
5.1.2. Anatomical Mask of Basal Ganglia and Prefrontal Cortex  
In this analysis we identified regions that demonstrated condition effects (instead of 
examining condition effects only within regions defined in the prior study) and found multiple 
regions within the left and right MFG demonstrated condition effects in response to the 
presentation of the update cue, as did one region in the left caudate. The pattern for regions 
within the MFG was that updating activity was significantly greater than maintenance, with no 
difference between interference control and maintenance. While interference control activity in 
this region was numerically higher than maintenance activity (Figure 4.3A) following 
presentation of the update cue, the fact that we did not find a significant difference between 
these conditions is not consistent with our previous work. It may be the case, however, that we 
generally lacked the power reliably to detect this subtle difference between the transient cortical 
response to distracter presentation and activity during the maintenance condition, even though 
our control sample in this data set is larger than the previous data set. That is, we found the 
same relative patterns of activity that we did in our previous study but given the difference 
between interference control and maintenance activity is small although the difference exists the 
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significance of this difference may vary across smaller samples. The region in the caudate also 
demonstrated greater updating than maintenance activity, but greater maintenance activity 
when compared with interference control activity. One explanation for this increase of activity 
during maintenance trails compared to interference trials within the striatum is that it may reflect 
a salient cue orientation signal (Redgrave, Gurney, & Reynolds, 2008), as discussed next. 
We used maintenance as a comparison condition because, unlike updating and 
interference control conditions, no shapes are presented during the update cue period. We 
assumed that there should be little to no change in striatal activity during this period given that 
striatal neuron projecting to the direct pathway would not activate in the absence of stimulus 
presentation and striatal neurons projecting to the indirect pathway are tonically active, and 
would not demonstrate a change of activation. After reviewing plots of time courses during the 
three different update cue conditions we see that this is not the case, and for many regions 
there is in fact mild to moderate increases of brain activity during the update cue period of 
maintenance trials. While no shapes were presented during this time empty boxes that are 
either red or green in color are presented and this presentation may be sufficient to elicit an 
increase of striatal activity, particularly in the caudate given that the boxes are salient and 
behaviorally relevant. A study by Zink et al. (2003) examined in humans the possibility that the 
striatum may function to process salient events regardless of reward value, rather than coding 
rewards and reward-related stimuli. They examined striatal response to nonrewarding salient 
stimuli using fMRI while manipulating the behavioral relevance of stimuli by manipulating 
salience by manipulating the frequency of distracter occurrence (such that high frequency 
resulted in less salience) and the behavioral relevance of the distracter (distracters that required 
a response and those that did not). They found that activity in both the nucleus accumbens and 
caudate increased in response to high salience nonrewarding stimuli, but activity in the caudate 
only did so when the stimuli was behaviorally relevant. Thus, increased caudate activity we 
observed during maintenance may reflect the salient, behaviorally relevant, properties of the 
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green and red boxes presented during maintenance trials. Further, increased maintenance 
activity compared with interference control activity may also reflect the increased salience of 
“no-shape” maintenance trials when compared with “ignore-shape” distracter trials, given that 
the majority of trials used in the task presented either one or two shapes and thus maintenance 
trials were less frequent. 
Specific Aim 1: Test the hypothesis that individuals with schizophrenia demonstrate 
dysregulated striatal activity during updating and interference control and that striatal 
activity predicts performance deficits. 
5.2. Condition Discussion 
To address our first aim we examined brain activity during updating, distracter 
presentation, and simple maintenance in both our independently defined ROIs and in an 
anatomical mask of the prefrontal cortex and the striatum. Given that patients with 
schizophrenia may have dysregulated striatal activity and that activity in the striatum may be 
associated with information gating, we predicted that patients would demonstrated an 
attenuated striatal response in response to updating demands and an attenuated response to 
task conditions cortically. We first examined diagnostic differences at the condition level to 
identify broad difference in responses to updating, distracter presentation, and simple 
maintenance in regions that were defined using a previous data set of healthy controls. Three 
regions demonstrated significant interactions of condition and diagnosis – two in the dorsolateral 
prefrontal cortex (DLPFC) and one region in the caudate. Patients demonstrated greater DLPFC 
activity for updating compared to maintenance activity and even significantly greater DLPFC 
activity during interference control when compared with maintenance. Within the caudate there 
were no differences between conditions for patients and a plot of the time course revealed poor 
separation between conditions following the update cue. Controls also demonstrated 
significantly greater update and interference control DLPFC activity when compared with 
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maintenance and no difference between conditions in the caudate, however a plot of the time 
course for controls revealed that there was separation between conditions but maintenance 
activity in the caudate that was intermediate to update and interference control activity. We did 
find that update and interference control activity for controls in the caudate significantly differed 
when we compared them directly. When comparing neural response to task demands between 
diagnostic groups we found that updating activity within the IFG and MFG for controls was 
significantly greater than updating activity within these regions for patients, but that there was no 
difference between groups when examining interference control activity within these regions and 
no differences between groups when examining caudate activity. So, while updating activity in 
the DLPFC for patients was significantly greater than comparison conditions, updating activity 
was still significantly lower than for controls. In the anatomical mask analysis, we found only one 
region in the MFG (BA 9) that demonstrated an interaction of condition and diagnosis.  In this 
region, controls demonstrated significantly greater updating activity when compared with 
maintenance (an numerically greater interference control activity compared with maintenance), 
whereas patients did not demonstrate significant differences between task conditions. When 
comparing the neural response to task demands between diagnosis groups we found no 
differences, although control activity to updating and interference control was numerically 
greater. 
These results provide some support for the hypothesis that patients would demonstrate 
dysregulated striatal activity during cognitive control demands, as evidenced by poor 
discrimination during 3 different task conditions. Interestingly, this was true when examining 
correct trials and this lack of discrimination was truer for the striatum than it was for regions 
within the DLPFC when examining our independently defined regions (Table 4.4), although 
activity for patients in one region of the DLPFC (MFG; -41, 30, 26; Figure 4.4) also 
demonstrated poor discrimination between conditions. Importantly, however, we also saw 
evidence for altered activity in the DLPFC. Of the DLPFC regions that demonstrated an 
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interaction of diagnosis by condition we also observed that the response to updating demands 
for patients within a region was numerically lower than controls. It is interesting that the regions 
demonstrating tasks effects within our anatomical masks correspond to segments of the 
striatum striatal that have anatomical and functional connectivity with the DLPFC. For example, 
Draganski et al. (2008) examined cortico-striatal connectivity using probabilistic tractography 
and a novel method of creating voxel-based connectivity profiles to represent projections from a 
source to multiple target regions, called voxel connectivity profiles, on magnetic resonance 
diffusion imaging data of 30 healthy subjects. The aim of the study was to compare basal 
ganglia and thalamic connectivity of humans with anatomical patterns demonstrated in 
nonhuman primates, and to provide evidence of pathways between spatially segregated regions 
of the basal ganglia/thalamus and cortical regions. Amongst other findings, they found that 
rostral and caudal regions within the caudate and putamen demonstrated strong connectivity 
with the DLPFC and orbital frontal cortex (OFC). These findings were supported by Barnes et al. 
(2010), who used a combination of resting state functional connectivity MRI and graph theoretic 
analyses to parcellate subcortical structures of individual subjects and found that the locations 
of significant cortical-basal ganglia functional connectivity was consistent with connectivity of 
basal ganglia segments described above. While there is good evidence for both anatomical and 
functional connectivity between segmented cortico-striatal loops, the nature of the relationship 
during cognitive control has yet to be fully elucidated. A critical question for future research is to 
what degree does altered activity in the striatum and the DLPFC reflect an abnormal functional 
loop, and whether some of the variance in DLPFC disruption in schizophrenia might actually 
reflect dysregulated striatal function. 
One way that cortico-striatal loops may impact cognitive control is through information 
gating, which may be accomplished through dense dopaminergic innervation of the striatum that 
transiently strengthen inputs to the frontal cortex, and by extending models of disinhibitory 
gating from the motor literature. As described in the introduction section, this gating mechanism 
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has been described computationally by Frank et al. (2001) and, more recently, by Hazy et al. 
(Hazy et al., 2007). In this model, dopamine based reinforcement-learning provides appropriate 
learning signals that train direct pathway medium spiny neurons (MSNs) in the dorsal striatum 
when to fire, inhibiting the substantia nigra, which then releases the thalamus from tonic 
inhibition. Thalamic disinhibition enables, but does not cause, excitation of a segregated cortico-
striatal loop and thus an information update, the same way that disinhibition via the basal 
ganglia sets a pattern of motor readiness in premotor networks rather than generating a 
command for muscular contraction (Chevalier & Deniau, 1990). Striatal spiny neurons in the 
indirect pathway are in competition with neurons in the direct pathway as they promote greater 
inhibition of thalamic neurons. In the prefrontal cortex, robust maintenance occurs through a 
combination of recurrent excitatory connectivity and bistability, which is toggled to and from a 
maintenance state via input from the basal ganglia. Hazy et al. (2007) also suggests that 
actively maintained representations in the prefrontal cortex may demonstrate top-down biasing 
of processing in relevant brain areas (e.g. posterior cortex, hippocampus, and basal ganglia), 
which may occur only when output-generating laminae within frontal cortical columns reach a 
threshold via basal ganglia-thalamic input signals (Hazy et al., 2007). Similarly, others suggests 
that dopamine and basal ganglia output may function to stabilize the information gate during 
distraction by enhancing task relevant memories in the cortex (Gruber et al., 2006) or that 
output from the basal ganglia gradually trains or builds up representations in the prefrontal 
cortex, and that without this input cortical representations are not as robust or distinct (Miller, 
2013). 
Based on the relationship between the prefrontal cortex and the basal ganglia described in 
the models discussed above, certain predictions could be made about how these regions will 
behave during specific task conditions. For example, during information updating one can 
expect that MSNs in the direct pathway will activate more strongly than MSNs in the indirect 
pathway, resulting in inhibition of the substantia nigra, disinhibition of the thalamus, and 
 74 
activation of the prefrontal cortex region within that cortico-striatal loop. During interference 
control, however, without appropriate dopaminergic input, MSNs in the indirect pathway will 
continue their tonic inhibition of the substantia nigra, which leads to inhibition of the thalamus 
and cortical regions within that segregated loop. The prefrontal cortex will activate in response 
to a distracter, but without basal ganglia-thalamic input signals this activation will not reach 
threshold. Thus, if dopamine signaling in the striatum were disrupted, as is the case with 
psychosis, one may expect that striatal output would be affected, perhaps though increased 
competition between direct and indirect MSNs resulting in weaker activation in response to 
updating demands, and with weaker basal ganglia-thalamic output to the cortex the cortical 
threshold would be more difficult to meet. Our finding that within the striatum patients 
demonstrated poor discrimination between conditions and appear to have an attenuated cortical 
response to updating demands are consistent with these predictions.  
The models also imply that increases of brain activity in dorsal striatal and prefrontal regions 
should be associated with an update occurring, regardless of whether the update should have 
happened, because the “gate” opens anytime information is admitted to working memory stores. 
Further, a failure to update should be associated with decreased striatal and prefrontal activity 
because the “gate” failed to open. If a participant were to inappropriately update a distracter, for 
example, we would expect to see similar patterns of prefrontal and striatal activity that we would 
see during an appropriate update. We explored this idea in our analysis of trial type accuracy. 
5.3. Trial type Accuracy Discussion 
 Given differences of behavioral accuracy between diagnostic groups during the Update 
and the Resist Distracter Lure trial types we examined whether brain activity during correct and 
incorrect trials differed within prefrontal and striatal regions, and across diagnostic groups. The 
Resist Distracter Lure trial is interesting because at the response probe participants are 
presented with items they should have ignored earlier during update cue. If participants indicate 
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that this items is correct it suggests that they inappropriately updated or attended to this item 
instead of ignoring it as instructed. This inappropriate update should be reflected in changes of 
brain activation during the update cue. Further, this analysis is interesting because it examines 
differences of brain activity between correct and incorrect Resist Distracter Lure trials that occur 
during time frames associated with the update cue, even though distinguishing feature between 
correct and incorrect trials is the response to the probe that occurs later. As predicted we found 
increased activity for incorrect trials compared with correct trials within a right DLPFC region 
and within the right putamen, but for patients not controls. For controls, activity within the 
DLPFC demonstrated no difference between correct and incorrect trials, and greater correct trial 
activity than incorrect trial activity within the putamen – the opposite pattern of patients with 
schizophrenia. This finding supports the idea that for patients, activity occurring in response to 
the update cue, even when instructed to ignore these items, meaningfully contributes to later 
behavioral accuracy at the probe. Not only did we find that there were differences in activity for 
correct trials and incorrect trials, suggesting that striatal activity was not simply a byproduct of 
arousal due to stimulus orientation, but we found greater activity during incorrect trials. This 
finding fits the prediction one would make based on the computational models of gating (e.g. 
Frank et al., 2001) described above, where increases of striatal and prefrontal activity are 
associated with gating information into working memory, and suggests that this processing will 
lead to a someone identifying an incorrect item as correctly matching a memory representation.  
We also examined whether cortical and subcortical brain activity differed between 
diagnostic groups during correct and incorrect Update trials. Correct responses during Update 
trials indicate that the participant correctly identified the “to-be-remembered” shape at the probe 
and incorrect trials indicate that the participant rejected the shape, suggesting they did not 
update or encode new information as instructed. Again, although correct and incorrect trials are 
defined by the response made at the probe, we examined activity that was associated with the 
presentation of the “to-be-remembered” items. Behaviorally, we found that patients and control 
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performance significantly differed for this trial type, although the effect was smaller for the 
Update (Cohen’s d = 0.66) versus the Resist Distracter Lure trial type (Cohen’s d = 0.97). With 
regard to brain activity, we found that bilateral globus pallidus activity for patients was 
significantly greater for correct than incorrect trials.  
In Hazy et al. (2007) model described above, the globus pallidus is associated with the 
indirect pathway and receives inhibitory input from striatal MSNs. This inhibition activates the 
globus pallidus, causing disinhibition of substantia nigra pars reticulata (which is tonically 
inhibited by the globus pallidus), and this disinhibition of the substantia nigra competes with 
inhibitory input from striatal MSNs associated with the direct pathway. Thus, increases of 
activation of the globus pallidus should disinhibit the substantia nigra, making it less likely that 
the cortex will be released from thalamic inhibition and less likely that an update will occur. Our 
finding of greater activity on correct versus incorrect trials in the globus pallidus in patients is not 
consistent with the predictions of the Hazy model, depending on where in particular the regions 
of the globus pallidus lie. However, this result might be consistent with the findings of McNab et 
al. (2008). They found that increases of globus pallidus activity, which preceded the 
presentation of distracters, was associated with increasing working memory storage. They 
suggested that the globus pallidus might function as an information filter that increases activity 
in response to relevant task information and decreases activity in response to irrelevant 
information. In this context it makes some sense that increases of activity within the globus 
pallidus are associated with correct trials of information updating as task relevant information is 
being filtered in and lower activity is associated with errors, but again we only found this pattern 
of effects for patients and not controls. Of the two globus pallidus regions that demonstrated a 
significant interaction of diagnosis and accuracy for Update trials, controls only demonstrated a 
difference between correct and incorrect trial activity within the left lateral globus pallidus, such 
that correct trial activity was significantly less than incorrect trial activity (Figure 4.6B) – the 
opposite pattern that patients displayed.  
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The findings from our trial type accuracy analyses provide some support our hypotheses 
from Aim 1, such that for patients striatal activity distinguished between correct and incorrect 
trials suggesting that increases of striatal activity during distracter presentation are associated 
with deficits of interference control. However, we did not find that striatal activity selectively 
distinguishes between correct and incorrect Resist Distracter Lure trials as a region in the 
DLPFC also demonstrated significant differences between correct and incorrect trial activity for 
patients. Further, we found evidence that for patients the globus pallidus significantly 
distinguished between correct and incorrect Update trial activity for patients, although the 
pattern of the effect again differed between diagnostic groups and was, perhaps, not consistent 
with the predictions of the Hazy model.  
Unfortunately, with our current design it is difficult to disentangle the causal contributions 
of prefrontal and striatal regions have on behavioral outcomes, given the relationship between 
basal ganglia output and prefrontal function described above. For example, it is possible that 
basal ganglia output precedes prefrontal activation and increases of activity represent 
information updating whereas prefrontal activity represents storage and maintenance related 
activity of the updated item. It is also possible that prefrontal activity during distracter 
presentation may occur first and increases of striatal activity result from downstream effects of 
cortical activity, perhaps through glutamatergic afferents from the cortex to spiny neurons in the 
striatum (Rosell & Giménez-Amaya, 1999). Further, we did not find the same pattern of activity 
during correct and incorrect Resist Distracter Lure trials for controls. If this cortico-striatal 
mechanism is indeed a mechanism of gating we should expect to see the same pattern of 
results regardless of diagnostic status. That is, if controls inappropriately update information it 
should be reflected in a neural response of the striatum and the prefrontal cortex. The fact that 
we failed to find differences between correct and incorrect trials for controls or the patterns we 
did find were the opposite of patients with schizophrenia might suggest that the activity we 
observed for patients reflects something might be specific to disease state and not directly 
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related gating. However, when examining brain activity in regions that showed interactions of 
accuracy and time for the Resist Distracter Lure and Update trials (e.g. right putamen, Table 4.6 
and right caudate, MFG and left IFG, Table 4.7) to explore the pattern of brain activity between 
groups as a function of accuracy, we found that for a region in the putamen that demonstrated 
an accuracy by time interaction both patients and controls demonstrated numerically greater 
incorrect Resist Distracter Lure trial activity than correct trial activity. Further, the activity for both 
patients and controls in regions that demonstrated an effect of Update accuracy by time did not 
appear to differ when comparing correct and incorrect trials to one another. Thus, we found 
some evidence that to suggest that patient and control activity during correct and incorrect 
Resist Distracter Lure and Update trials is more comparable, but further work is need to 
determine if the counterintuitive finding that patients and controls demonstrate opposite patterns 
of brain activity during task performance.  
It may also be the case that errors made by controls were related to processing deficits 
that had little to do with the inappropriate processing of distracters during the update cue, and 
were related to other factors that made them error prone (e.g. inattention at the probe). If this 
were the case the neural signature that would distinguish correct from incorrect trials may not 
have occurred in either prefrontal or striatal regions, and may have occurred at some other point 
during the trial than the update cue response period. Another possibility is that we simply lacked 
a sufficient number of error trials for controls to detect reliable differences of brain activity 
between correct and incorrect trials, given that patients’ behavioral performance was 
significantly worse than controls for both Resist Distracter Lure and Update trial types. While it is 
difficult to make conclusive statements about the trial type accuracy results from our control 
sample, it was clear that patients demonstrated increased susceptibility to distracters, with a 
large effect size, and poorer updating behaviorally, and that these performance deficits were 
associated with striatal and prefrontal activity during update cue presentation. 
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Specific Aim 2: Test the hypothesis that in individuals with schizophrenia, increased 
striatal activity during distracter presentation will be positively associated with aberrant 
salience symptoms, delusions, and hallucinations of patients with schizophrenia. 
5.4. Relationship between Symptoms and Brain Activity Discussion 
Our second aim was to identify a relationship between behavioral deficits of cognitive control, 
brain activity associated with these deficits, and symptom expression. More specifically, we 
predicted that striatal activity of patients would demonstrate a relationship between cognitive 
control deficits and aberrant salience symptom expression given the possibility that mechanisms 
of cognitive control may also be involved in regulating salience assignment.  
The results of our Trial Type Accuracy analysis revealed that, for Resist Distracter Lure trials, 
patients demonstrated increased activity both in the striatum and DLPFC when an inappropriate 
update may have occurred. We examined whether this activity was associated with aberrant 
salience, other measures of psychosis proneness, and anhedonia. We found that only striatal 
activity during incorrect trials correlated significantly with aberrant salience, such that individuals 
with higher striatal activity during incorrect trials had higher aberrant salience scores. Further, 
we found that within the same striatal region, the correlation between aberrant salience and 
incorrect trial activity was stronger than the correlation between aberrant salience and incorrect 
trial activity, suggesting some specificity, although the effect was only at trend level. When 
examining the relationship between striatal activity and other psychosis proneness scores we 
found that both correct and incorrect trial activity in the striatum similarly correlated with another 
psychosis proneness measure (magical ideation; r = 0.45 and r = 0.43, respectively) and not, 
importantly, with measures of anhedonia. We included measures of anhedonia to contrast the 
relationship between brain activity and symptoms associated with positive symptoms and 
symptoms associated with negative symptoms. We predicted that if brain activity associated 
with cognitive control gating should be more strongly associated with positive symptoms than 
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negative symptoms given that altered salience assignment is primarily an explanation of 
psychotic symptoms associated with schizophrenia as discussed by Kapur (2003). Thus, while 
patient striatal activity during Resist Distracter Lure trials was more broadly correlated with 
positive symptoms, aberrant salience was selectively associated with errors associated with 
deficits of interference control. Within the DLPFC, we found no significant correlation between 
any of the symptom measurements for patients and brain activity.  For controls, we found no 
significant correlation between aberrant salience and brain activity.  There was a relationship 
between activity in the striatum and DLPFC and positive symptoms and anhedonia in controls, 
but in an opposite direction than that found for patients. 
Results from the Update trial type analysis for patients revealed somewhat similar 
results, such that increases of globus pallidus activity during correct trial only were significantly 
correlated with aberrant salience and other measures of psychosis proneness and anhedonia. 
So again, we find that for patients greater basal ganglia activity is associated with greater 
symptom expression of aberrant salience, but also greater expression of psychosis proneness 
and anhedonia, although left lateral globus pallidus was selectively correlated with psychosis 
proneness and not anhedonia. For controls, we found negative correlations between correct and 
incorrect Update trial globus pallidus activity and aberrant salience, psychosis proneness, and 
anhedonia. Again, this was the opposite pattern that we observed for patients.  
The reversed direction of correlations between brain activity and symptom scores in 
patients versus controls was unexpected, but perhaps not too surprising given patients and 
controls demonstrated the opposite pattern of brain activity during correct and incorrect Resist 
Distracter Lure and Update trials. However, that explanation does not fully account for why, at 
and individual level, symptom expression increases for controls as brain activity decreases. It is 
possible that differences in the degree to which patients and controls express symptoms may 
have impacted our results. For example, all measures from the Chapman scales demonstrated 
significant differences between patients and controls, which may make one wonder if symptom 
 81 
expression for controls was at floor levels with little variation across individuals. It is important to 
point out that there was only a trend level difference of aberrant salience symptoms between 
patients and controls, suggesting variation of symptom expression was somewhat comparable 
between patients and controls. One benefit of the ASI is that it was determined to be a valid 
measure of aberrant salience for both clinical and nonclinical samples (Cicero et al., 2010). 
Thus, ASI symptoms expressed some range across individuals, but do these symptoms 
correlate with other measures of psychosis proneness and anhedonia in the way we would 
expect them to? We found that within the control sample aberrant salience was highly correlated 
with psychosis proneness but not anhedonia, providing evidence of discriminant validity within 
our nonclinical sample. So, while symptom expression for controls in this sample is lower than 
patients we have some evidence suggesting symptom expression within our control sample 
demonstrates some variability and behaves as expected. Even so, the correlations between 
brain activity during task performance and aberrant salience for controls were almost uniformly 
negative, like they were for other measures of psychosis proneness and anhedonia.  
One potential interpretation of these findings is that they perhaps run contrary to the idea 
that psychotic experience exists as a part of a continuum (described previously by Linscott & 
van Os, 2010), or that psychotic experiences and odd thinking exist to a lesser degree in 
nonclinical sample and are produced by some of the same mechanisms that produce these 
symptoms in clinical samples. For example, we found that psychotic symptoms that presumably 
have the same underlying mechanism correlated differently with striatal activity between 
patients and controls. Others that have examined the relationship between brain activity and 
psychosis proneness of healthy individuals, to detect regions associated with psychotic 
symptom expression within nonclinical samples, have found mixed results. For example, 
Ettinger et al. (2013) examined psychosis proneness and neural activation during a procedural 
learning task, thought to be sensitive to sensitive to dopamine fluctuation, and found positive 
correlations between psychosis proneness and, amongst other regions, the caudate, putamen, 
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and frontal regions. However, these findings were not consistent with previous work of theirs 
examining the relationship between psychosis proneness and fronto-striatal-thalamic brain 
activity during involuntary or voluntary inhibition (from Ettinger et al., 2013), where they found 
negative relationships between brain activity and psychosis proneness. They suggest that this 
may be explained by differential influences of dopamine on tasks involving inhibition and tasks 
involving procedural learning. Further, Corlett et al. (2012) examined the relationship between 
brain activity during prediction error and psychosis proneness for a sample of healthy volunteers 
and found negative correlations between symptom expression and brain activity in the dorsal 
striatum and DLPFC, however they do not interpret the direction of this finding. Further work is 
needed to clarify some of the causal neural mechanisms of psychotic symptom expression 
within nonclinical samples and the degree to which similar relationships are found in clinical and 
non-clinical samples 
Regarding the relationship between aberrant salience and brain activity for individuals 
with schizophrenia, our findings of a relationship between aberrant salience and dorsal striatal 
activity are somewhat distinct from previous studies. For example, Roiser et al. (2009) 
examined whether patients with schizophrenia demonstrated deficits of motivational incentive 
salience, or learning stimulus-reinforcement associations where neutral stimuli acquire 
relevance through primary reinforcement and subsequently influence behavior. They used a 
novel task, the Salience Attribution Task (Schmidt & Roiser, 2009), that required participants to 
make speeded responses to earn money in the presence of conditioned stimuli, and found that 
while some patients demonstrated adaptive motivational salience acquisition patients with 
greater delusional symptoms demonstrated aberrant salience acquisition. However, they found 
that aberrant salience was correlated only with negative symptoms. Using the same task they 
examined the neural basis of adaptive motivational salience acquisition in healthy controls and 
found that higher cue relevance was associated with increased activity within the ventral 
tegmental area and its dopaminergic projections, including the thalamus, ventral striatum, and 
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prefrontal cortex – regions previously implicated in motivational salience – and positive 
correlations between brain activity and adaptive reward learning (Roiser, Stephan, Ouden, 
Friston, & Joyce, 2010). This same group examined whether patients at high-risk for developing 
psychosis demonstrated aberrant incentive salience as well as altered dopamine synthesis 
capacity and brain activity relative to controls during salience acquisition. While they found no 
group differences between aberrant reward prediction and no difference between dopamine 
synthesis capacity, they did find aberrant salience acquisition behaviorally for the high-risk 
group that differed relative to controls and a positive correlation between ventral striatal 
responses and inappropriate salience assignment (Roiser, Howes, Chaddock, Joyce, & 
McGuire, 2013).  
Taken together, these findings provide some evidence demonstrating that aberrant 
incentive salience is associated with psychosis and psychosis risk, and that as expected 
salience acquisition is associated with brain regions previously identified to be associated with 
this type of learning, including the ventral striatum. However, they acknowledge the conundrum 
that despite the relationship between the ventral striatum and motivational incentive salience 
acquisition, in schizophrenia the largest dopamine abnormality, thought to underlie deficits of 
salience acquisition, occurs in the dorsal rather than the ventral striatum (Howes et al., 2012). 
For patients the relationship between the dorsal striatum function, increased presynaptic 
dopamine storage and release with the dorsal striatum, aberrant salience and cognitive deficits 
associated with the disorder have been unclear. As such, the current study is the first to identify 
a relationship between dorsal striatal activity, cognitive control deficits associated with 
schizophrenia, and clinical symptom expression of psychotic symptoms.  
5.5. Limitations 
 Limitations of the study include the relatively modest sample size. These results should 
be replicated in a larger, independent sample to support these findings. Upon reviewing the time 
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course of activity during the Condition and Trial Type analysis we observed that patients 
seemed to have lower activity than controls in response to the presentation of the memory set 
(e.g. Figure 4.4). It is possible that behavioral deficits we observed were the results of goal 
representation deficits associated with schizophrenia (reviewed in Barch & Ceaser, 2012). 
Failing to adequately encode the memory set would significantly impair the ability of participants 
to respond appropriately to update cues and make correct responses when probed. The impact 
of goal representation deficits, while not a focus of this current study, is something that warrants 
further exploration given that it may be a common mechanism of cognitive dysfunction for 
schizophrenia. We should note, however, that we did not find significant differences between 
patients and controls behaviorally on measures of simple maintenance and maintenance when 
presented with distracters. That is, when tasked to simply maintain information over time 
patients and controls had comparable maintenance performance, even when presented with 
distracting information in the interim. Thus, there is evidence that patients are able to maintain 
information over time but their performance decreases as task demands become more complex 
(i.e. making an information update, ignoring distracters, etc).  
Further, aberrant salience theories of symptom expression are based on findings of 
increased dopamine synthesis capacity within the associative striatum for patients with 
schizophrenia and thus altered striatal dopamine signaling. Altered dopamine signaling was not 
something that was measured in this study, and thus it is not clear to what extent our findings 
related to this dysfunction for patients with schizophrenia. Further work is needed to determine if, 
for example, aberrant salience symptoms correspond to changes of dopamine fluctuation or if it 
is associated with increased striatal activity for patients during distraction. The relationship 
between brain activity, dopamine signaling, and psychosis proneness is also something that 
warrants further study, as it is not clear whether subclinical symptoms expressed by non-
psychotic individuals result from the same mechanism that brings about these symptoms for 
psychotic individuals. Or, perhaps a better question is what mechanisms are sufficient to bring 
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about subclinical symptom expression assuming that multiple mechanisms contribute to 
symptom expression? It was difficult to interpret the results of our control sample given this 
ambiguity, but what was clear was that patients and controls demonstrated different patterns of 
brain activity in response to the same task conditions and for individual subjects there were 
different patterns of relationships between brain activity and symptom expressions for patients 
and controls.  
This study also lacked a psychiatric control group. We found differences between patients 
and controls and we believe that these differences reflect disease pathology that is specific to 
psychosis and schizophrenia. However, it may also be the case that these differences we 
observed are present when comparing individuals with schizoaffective, bi-polar disorder, or a 
mood disorder. Thus, future work would need to test whether the differences between patients 
and controls observed in this study are specific to schizophrenia, generalize to symptoms of 
psychosis more broadly, or are also present when comparing healthy individuals with individuals 
who have diagnosable mental illness that do not involve psychosis. It is important to note that 
aberrant salience and the mechanisms that are thought to underlie aberrant salience symptoms 
are not specific to schizophrenia. As discussed in Howes et al., (2009), about 8% of the 
population report psychotic experiences, and dopamine dysfunction has been observed in 
family members of those individuals with schizophrenia, individuals with schizoptypy, and those 
at high risk for developing psychosis. So, while our patient population consists of individuals 
diagnosed with schizophrenia we believe that, because the underlying mechanism of aberrant 
salience is the same, the striatal dysregulation and association with aberrant salience symptoms 
will be present in other individuals experiencing, or at risk for experiencing, psychotic symptoms. 
However, the question of whether differences we observed between diagnostic groups is 
present when comparing psychotic and non-psychotic patient groups. With regard to aberrant 
salience symptoms, to some degree this question was addressed by Cicero et al. (2010). They 
examined aberrant salience scores of individuals with psychosis who were inpatients at a 
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forensic state hospital with a psychiatric comparison group who were also inpatients at said 
hospital. The psychiatric comparison group was composed of a variety of patients with 
nonpsychotic diagnoses, including bipolar I, II, and NOS, mood disorder NOS, personality 
disorders, posttraumatic stress disorder. These individuals were taking psychotropic medication, 
including mood stabilizers, antidepressants, as well as antipsychotics. They found significant 
differences between the psychosis group and the non-psychosis group such that the psychosis 
group had higher ASI scores than the non-psychosis group, suggesting that when controlling for 
illness acuity and possibly even antipsychotic medication use aberrant salience is greater for 
individuals with a history of psychosis.  
Finally, it is possible that antipsychotic use by our patient participants may have influenced 
their results. Patient participants in this study were required to be stable on their medication for 
at least 2 weeks prior to study participation. We did not assess what medications patients were 
prescribed due to complexities with gathering this information that could result in, at best, 
inaccurate or, at worst, misleading information about medication use and its effect on our results. 
For example, there are differences between what medications a patient has been prescribed, 
what medications a patient remembers being prescribed, what medications patients are actually 
taking, and the extent of dopamine blockade occurring in the brain of patients – the latter point 
being what we are ultimately interested in measuring. Thus, the relationship between self-report 
measures of medications use and dopamine blockade are unclear. This is not to say, however, 
that the influence medication use has had on our results is irrelevant. As discussed above, 
increased presynaptic dopamine and subsequent dopamine release is thought to underlie 
symptoms of aberrant salience. There is evidence demonstrating a relationship between 
treatment response to medication and increased presynaptic dopamine synthesis capacity 
(Demjaha et al., 2012), so it may be the case that because our patients were stable on their 
medications the amount of dopamine release resulting from increased presynaptic dopamine 
concentrations was reduced due to antipsychotic blockade. That is, antipsychotic medication 
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use by our patient participants may have reduced aberrant salience symptoms and thus 
attenuated the relationship between symptom expression and brain activity we observed. 
However, without a direct measure of dopamine fluctuation it is difficult to say with, any certainty, 
what effect medication use by patients has had on our results.  
5.6. Conclusions 
To our knowledge, this is the first study to find a relationship between dorsal striatal activity, 
cognitive control, and aberrant incentive salience, described by Kapur (2003), in patients with 
schizophrenia. We found evidence consistent with the hypothesis that the basal ganglia, 
particularly the associative striatum, may meaningfully contribute to the processing of cognitive 
control demands via information gating. Further, while we found evidence that both the striatum 
and DLPFC demonstrated altered activity during task demands, we found that for patients with 
schizophrenia striatal activity was selectively associated with the expression of aberrant 
salience symptoms, symptoms that are thought to result from dysregulated dopamine signaling. 
These findings provide potential treatment targets that could improve symptoms and functional 
outcome of patients with schizophrenia. For example, cognitive remediation that improves the 
regulation of information gating, a core component of executive control, an important predictor 
of functional outcome of severe mental illnesses (Berk et al., 2013; Martinez-Aran et al., 2002; 
2007), should also impact aberrant salience symptom expression. Our future work will focus on 
further exploring the relationship between deficits of cognition associated with psychosis and 
brain functioning with the aim of developing more effective treatments for individuals with 
schizophrenia that will ultimately improve their quality of life.  
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7. Figure Captions 
Figure 2.1: Controlled Update Task Design. Trials representing the 3 update cue events 
(Upgreen, Upred, and Upempty). For each trial participants are first shown two shapes, the first 
one for 1.5 seconds and then a second for 1.5 seconds. They are instructed to remember these 
shapes in the order that they were presented. After a 7 second delay (Delay 1), 1 of 3 update 
cue conditions occurs. During the Upgreen condition participants are shown either 1 or 2 new 
shapes (one after another) framed in green and are tasked with replacing 1 or both of the 
corresponding memory set items. During the Upred condition particpants are shown 1 or 2 new 
shapes framed in red and are instructed to ignore these shapes and to continue remembering 
the items from the memory set. During the Upempty condition participants are shown empty 
boxes that are either red or green. They are told that if no new shape is presented during the 
update cue they are to simply continue remembering the items from the memory set. Each box 
during the update cue is presented for 1.5 seconds. A second delay (Delay 2) follows the 
update cue, after which the probe is presented for 2 seconds. During the probe participants are 
presented a shape and asked if it matches one of the shapes that they are currently 
remembering. They respond by pressing a “yes” button or a “no” button. Probe types vary for 
each update cue condition. During Upgreen, for example, participants can be probed with a 
shape presented during the update cue that they should have remembered (Update trial type), 
to which they should respond “yes”. Or, during an Upred trial participants can be probed with an 
item presented during the update condition that they should have ignored (Resist Distracter 
Lure trial type), to which they should respond “no”. 
Figure 4.1: Task Accuracy for Diagnostic Groups. Task accuracy for patients (burgundy) and 
controls (green). While generally patients performed numerically worse than controls on all trial 
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types, these differences were only significant for the Resist Distracter Lure, Update trial types, 
and Resist Maintenance trials. *p<0.05 and **p<0.01. 
Figure 4.2: Brain Activity of Healthy Controls and Patients Within Regions Defined in a 
Previous Data Set. The figures above list the full trial time course of brain activity of healthy 
controls and patients from the current data set within regions defined in a previous data set. 
Green lines represent Upgreen activity, red lines represent Upred activity, and blue lines 
represent Upempty activity. “Memory Set” in the figure denotes the period during which the 
memory set items are presented. “Update Cue” in the figure and the two arrow lines represent 
the onset (10 seconds) and offset (13 seconds) of the update cue event. The gray box (16-24 
seconds) represents the time frame used in our follow up update cue analyses (corresponding 
to frames 8-12), which is shifted from the offset of the update cue to account for hemodynamic 
lag. “Probe” in the figure and the arrow line at the 22 second time point indicate the onset of the 
probe. We plotted the time course of brain activity for patients and controls for two 
representative regions, left lateral inferior frontal gyrus (IFG) and left lateral putamen, that 
demonstrated significant effects of condition for healthy controls went on to significantly interact 
with diagnosis. The regions that time courses were taken from appear in the cross hairs of the 
brain figure. Controls are listed in the first column (Figure 4.2A and 3C) and patients are listed in 
the second column (Figure 4.2B and 3D). These regions were selected because they represent 
a region in the frontal cortex and the striatum that demonstrated condition effects for controls. 
For controls we observed significant differences between Upgreen and Upempty during frames 
8-12 (16-24 seconds) for the IFG (-39, 4, 30) and putamen (-18, -3, 13). We also observed a 
significant difference between Upred and Upempty for the region in the IFG, but not the 
putamen region for controls. The region in the IFG went on to interact with diagnosis. Patients 
demonstrated a significant difference between Upgreen and Upempty during frames 8-12 (16-
24 seconds) for the IFG (-39, 4, 30) and a trend towards difference between Upred and 
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Upempty (F(1,21) = 3.06, p = 0.095). For putamen activity of patients, we observed no 
differences between either Upgreen and Upempty or Upred and Upempty. 
Figure 4.3: Regions of Healthy Controls from the Current Data Set that Demonstrated 
Effects of Condition. Time courses for representative regions from the frontal cortex and 
striatum derived from our current sample of controls that demonstrated condition effects 
following the update cue. Green lines represent Upgreen activity, red lines represent Upred 
activity, and blue lines represent Upempty activity. We found that both regions demonstrated 
significant differences between Upgreen and Upempty, but only the caudate demonstrated 
differences between Upred and Upempty. However, we found the unexpected pattern that 
Upempty activity was greater than Upred activity. 
Figure 4.4: Frontal Region from the Current Data Set that Demonstrated A Diagnosis by 
Condition Interaction. The time courses for a region in the middle frontal gyrus that 
demonstrated an interaction of diagnosis and condition during frames 8-12 (gray box in the 
figure). Green lines represent Upgreen activity, red lines represent Upred activity, and blue lines 
represent Upempty activity. Again, we found that control participants demonstrated significantly 
greater Upgreen versus Upempty activity in this region, and Upred activity was intermediate to 
Upgreen and Upred (the difference between Upred and Upempty, however, was not significant). 
Patients, however, did not demonstrate a difference between the three condition types. 
Figure 4.5: Regions Demonstrating a Diagnosis by Resist Distracter Lure Trial Type 
Accuracy interaction. We plotted the 2 regions (putamen, 23, 0, 4 and MFG, 40, 13, 30) that 
demonstrated diagnosis by Resist Distracter Lure accuracy following the presentation of the 
update cue. Red lines in the figure represent incorrect trial activity and blue lines represent 
correct trial activity. During Resist Distracter Lure participants are probed with an item they were 
instructed to ignore. If participants respond “no” they are correctly rejecting this item. However, if 
participants respond “yes” it suggests that they inappropriately updated this item when it was 
presented. “Memory Set” in the figure denotes the period during which the memory set items 
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are presented. “Update Cue” in the figure and the two arrow lines represent the onset (10 
seconds) and offset (13 seconds) of the update cue event. The gray box (16-24 seconds) 
represents the time frame used in our follow up update cue analyses (corresponding to frames 
8-12), which is shifted from the offset of the update cue to account for hemodynamic lag. 
“Probe” in the figure and the arrow line at the 22 second time point indicate the onset of the 
probe. For both the putamen (top row of the figure) and MFG (bottom row of the figure) we 
found that for patients incorrect trial activity was significantly greater than correct trial activity for 
frames 8-12 (16-24 seconds during the trial), consistent with the idea that increases of brain 
activity in these regions are associated with information updating. For controls we found the 
opposite pattern, such that incorrect trial activity was significantly less than correct trial activity 
for the putamen, and numerically, but not significantly, less than correct trial activity in the MFG. 
Figure 4.6: Regions Demonstrating a Diagnosis by Update Trial Type Accuracy interaction. 
We plotted the regions in bilateral globus pallidus that demonstrated diagnosis by Update 
accuracy following the presentation of the update cue. Red lines in the figure represent incorrect 
trial activity and blue lines represent correct trial activity. For the Update trial type participants 
are probed with an item they should have updated during the update cue. A “yes” response 
indicated they made the appropriate update, and a “no” response suggests that they did not. For 
both regions of the globus pallidus patients demonstrated significantly less activity during 
incorrect trials when compared with correct trials, again consistent with the idea that increases 
of brain activity in these regions are associated with information updating. However, for controls 
we again found the opposite pattern to patients when comparing correct and incorrect trial 
activity. Controls, on the other hand, demonstrated the opposite pattern of patients, such that 
activity in the left globus pallidus during incorrect trials following the presentation of the update 
cue was significantly greater than activity during correct trials. Activity in the right globus pallidus 
for controls did not significantly differ when comparing correct and incorrect Update activity 
following the presentation of the update cue. 
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Figure 4.7: Scatter Plots Depicting the Relationship Between ASI and Brain activity during 
Incorrect Resist Distracter Lure Trials. We observed a significant positive correlation 
between ASI and brain activity in the right lateral putamen during incorrect Resist Distracter 
Lure trials for patients but not controls, such that, as predicted, the brain activity for patients who 
were susceptible to distraction increased as ASI symptoms increased. If anything, putamen 
activity of controls demonstrated a non-significant correlation in the opposite direction. While we 
also observed a positive correlation between MFG activity during incorrect Resist Distracter 
Lure trials and ASI scores for patients, this correlation did not reach significance. 
Figure 4.8: Scatter Plots Depicting the Relationship Between ASI and Brain activity during 
Incorrect Update Trials. We observed a significant positive correlation between ASI and brain 
activity during correct Update trials in the left and right lateral globus pallidus for patients but not 
controls, such that the brain activity for patients during updating increased as ASI symptoms 
increased. This relationship was not expected, and suggests basal ganglia reactivity more 
broadly is associated with increased ASI. For controls, we found no significant relationship 
between brain activity and ASI in these same regions. 
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Appendix A 
Multislice image of anatomical masks of the prefrontal cortex and basal ganglia 
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Appendix B 
Regions from the Current Data Set that Demonstrated Diagnosis by Condition Effects Within the Whole Brain 
X Y Z Size Hemi Region BA Effect at frames 8-12 Direction (Patients) Direction (Controls) 
              
Analysis F p 
Upgreen vs. 
Upempty 
Upred vs. 
Upempty 
Upgreen vs. 
Upempty 
Upred vs. 
Upempty 
Condition 
-43 -69 -6 81 Left  Inferior Occipital Gyrus 19 
35 -77 3 196 Right  Middle Occipital Gyrus 19 
-39 -40 40 69 Left  Inferior Parietal Lobule 40 
-39 0 52 24 Left  Middle Frontal Gyrus 6 
Diagnosis 
-20 -5 11 33 Left  Putamen 
19 -17 7 122 Right  Thalamus 
-18 -17 0 62 Left  Thalamus 
-47 -50 -12 29 Left  Fusiform Gyrus 37 
45 -49 -7 25 Right  Sub-Gyral 37 
-42 16 4 234 Left  Insula 13 
36 15 4 62 Right  Insula 13 
-55 -36 1 23 Left  Middle Temporal Gyrus 22 
-40 44 10 80 Left  Middle Frontal Gyrus 46 
-31 -53 35 173 Left  Inferior Parietal Lobule 40 
-45 -2 36 107 Left  Precentral Gyrus 6 
37 6 32 23 Right  Precentral Gyrus 9 
27 -64 32 21 Right  Precuneus 7 
-4 11 57 240 Left  Superior Frontal Gyrus 6 
29 -68 -37 261 Right  Inferior Semi-Lunar Lobule 
-23 -70 -46 76 Left  Inferior Semi-Lunar Lobule 
-2 -74 -40 24 Left  Inferior Semi-Lunar Lobule 
-34 -67 -31 23 Left  Pyramis 
Condition X Diagnosis  
18 -43 43 30 Right  Precuneus 7 Dx X Cond 16.42 <0.001 no diff G < E** no diff R < E** 
Condition X Time 
18 5 11 85 Right  Putamen 
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-19 -4 9 290 Left  Lateral Globus Pallidus 
0 -68 15 5869 Left  Posterior Cingulate 31 
21 33 -11 30 Right  Middle Frontal Gyrus 11 
-40 -8 -14 22 Left  Sub-Gyral 21 
11 60 -6 21 Right  Superior Frontal Gyrus 10 
-51 12 -1 54 Left  Superior Temporal Gyrus 22 
-19 -34 -2 44 Left  Parahippocampal Gyrus 27 
-56 -37 -3 36 Left  Middle Temporal Gyrus 21 
18 -33 0 63 Right  Parahippocampal Gyrus 27 
-2 -42 17 226 Left  Posterior Cingulate 29 
-7 11 41 2292 Left  Cingulate Gyrus 32 
5 -79 21 38 Right  Cuneus 18 
47 -33 23 22 Right  Insula 13 
-3 -36 46 49 Left  Precuneus 7 
29 21 8 24 Right  Claustrum 
-28 23 4 34 Left  Claustrum 
32 -65 -46 28 Right  Inferior Semi-Lunar Lobule 
Diagnosis X Time 
18 -23 24 31 Right  Caudate 
-18 -5 23 22 Left  Caudate 
32 -90 -16 36 Right  Inferior Occipital Gyrus 18 
47 -58 -11 94 Right  Fusiform Gyrus 37 
-45 -76 -13 64 Left  Fusiform Gyrus 19 
-23 -86 -8 125 Left  Inferior Occipital Gyrus 18 
3 33 3 208 Right  Anterior Cingulate 24 
27 28 -4 24 Right  Inferior Frontal Gyrus 47 
-51 0 21 475 Left  Inferior Frontal Gyrus 44 
-39 43 7 114 Left  Middle Frontal Gyrus 46 
-31 24 3 41 Left  Inferior Frontal Gyrus 45 
-5 -100 7 50 Left  Cuneus 18 
55 1 8 22 Right  Precentral Gyrus 6 
-41 33 24 59 Left  Middle Frontal Gyrus 46 
-44 -62 18 24 Left  Middle Temporal Gyrus 39 
25 7 27 50 Right  Middle Frontal Gyrus 8 
52 -8 30 73 Right  Precentral Gyrus 6 
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27 -66 33 97 Right  Precuneus 7 
-31 -52 35 254 Left  Inferior Parietal Lobule 40 
49 21 27 33 Right  Middle Frontal Gyrus 46 
0 40 41 49 Left  Medial Frontal Gyrus 8 
-1 -46 37 47 Left  Precuneus 31 
37 -43 47 114 Right  Inferior Parietal Lobule 40 
-26 1 48 47 Left  Middle Frontal Gyrus 6 
-5 8 61 154 Left  Superior Frontal Gyrus 6 
-2 -25 64 28 Left  Medial Frontal Gyrus 6 
-16 -27 65 22 Left  Precentral Gyrus 4 
-28 -34 67 28 Left  Postcentral Gyrus 2 
-14 -40 -46 29 Left  Cerebellar Tonsil 
31 -64 -49 27 Right  Inferior Semi-Lunar Lobule 
-36 -60 -47 24 Left  Cerebellar Tonsil 
-24 -53 -46 49 Left  Cerebellar Tonsil 
33 -65 -29 81 Right  Tuber 
-22 -58 -25 50 Left  Culmen 
Condition X Time X Diagnosis 
-41 -74 -9 21 Left  Fusiform Gyrus 19 Dx X Cond 3.64 0.04 G > E** R > E** G > E** R > E** 
-40 -45 43 45 Left  Inferior Parietal Lobule 40 Dx X Cond 5.98 0.004 no diff no diff G > E** no diff 
-5 10 58 72 Left  Superior Frontal Gyrus 6 Dx X Cond 8.58 <0.001 no diff no diff G > E** no diff 
Regions from the current data set that demonstrated task effects in the whole brain. They are organized on the left side under headings like 
“Diagnosis” or “Condition X Time” based on whether they demonstrated these effects when examining all 15 time frames of the trial. Because we 
were only interested in regions that demonstrated effects that interacted with both diagnosis and condition we only conduced follow up tests on these 
regions. Statistics from the update cue response analysis can be found under the heading “Effect at frames 8-12”. G = Upgreen trials, E = Upempty 
trials, and R = Upred trials. *p<0.05 and **p<0.01, uncorrected. “no diff” signifies no statistically significant difference.
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Appendix C 
Regions Demonstrating an Effect of Diagnosis by Resist Distracter Lure Trial Type Accuracy within the Whole Brain 
X Y Z Size Hemisphere Region BA Effect at frames 8-12 Correct vs. Incorrect 
       
Analysis F p Patients Controls 
Diagnosis 
-43 -6 34 105 Left  Precentral Gyrus 6 
-26 -58 32 52 Left  Angular Gyrus 39 
-8 22 41 21 Left  Cingulate Gyrus 32 
23 -2 41 25 Right  Middle Frontal Gyrus 6 
-5 9 58 63 Left  Superior Frontal Gyrus 6 
43 -64 -26 30 Right Cerebellum Tuber 
Accuracy 
-30 -59 39 29 Left  Angular Gyrus 39 
-34 -26 54 59 Left  Precentral Gyrus 4 
Diagnosis X Accuracy 
34 14 38 23 Right  Middle Frontal Gyrus 8 Dx X Acc 21.56 <0.001 cor < incor cor > incor 
47 -10 45 25 Right  Precentral Gyrus 4 Dx X Acc 11.69 0.002 cor < incor cor > incor 
Accuracy X 
Time 
17 -18 8 47 Right  Thalamus 
-11 -21 12 54 Left  Thalamus 
2 61 0 77 Right  Middle Frontal Gyrus 10 
-34 12 2 24 Left  Insula 13 
-50 -16 14 129 Left  Postcentral Gyrus 43 
-33 -14 11 22 Left  Insula 13 
-4 -54 7 28 Left  Posterior Cingulate 30 
10 -68 28 59 Right  Cuneus 7 
-4 -66 45 217 Left  Precuneus 7 
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-3 26 34 21 Left  Cingulate Gyrus 32 
-39 -26 55 58 Left  Postcentral Gyrus 3 
5 -51 -1 57 Right Cerebellum Culmen 
17 -65 -16 56 Right Cerebellum Declive 
Diagnosis X 
Time 
-22 -7 28 21 Left  Caudate 
0 -33 9 36 Right  Thalamus 
49 -61 -12 116 Right  Fusiform Gyrus 37 
33 -39 -15 21 Right  Fusiform Gyrus 20 
-43 -75 -13 33 Left  Fusiform Gyrus 19 
-15 41 -4 65 Left  Anterior Cingulate 32 
-41 44 11 26 Left  Middle Frontal Gyrus 10 
-37 32 18 25 Left  Middle Frontal Gyrus 46 
46 19 24 33 Right  Middle Frontal Gyrus 46 
-11 -22 70 88 Left  Medial Frontal Gyrus 6 
-35 42 30 57 Left  Middle Frontal Gyrus 9 
-25 -64 31 37 Left  Precuneus 7 
27 -66 31 32 Right  Precuneus 7 
39 -42 50 196 Right  Inferior Parietal Lobule 40 
27 -15 63 115 Right  Precentral Gyrus 6 
-42 15 40 24 Left  Precentral Gyrus 9 
-36 -45 47 43 Left  Inferior Parietal Lobule 40 
0 -72 -13 23 Left Cerebellum Declive of Vermis 
-24 -80 -25 35 Left Cerebellum Uvula             
Regions from the current data set that demonstrated diagnosis by Resist Update Lure accuracy. They are organized on the left side under 
headings like “Diagnosis” or “Accuracy” based on whether they demonstrated these effects when examining all 15 time frames of the trial. 
We only conducted follow up analyses for the update cue period on regions that demonstrated a significant interaction of accuracy and 
diagnosis. Statistics from the update cue response analysis can be found under the heading “Effect at frames 8-12”. “cor” = correct trials and 
“incor” = incorrect trials. *p<0.05 and **p<0.01, uncorrected. “no diff” signifies no statistically significant difference.
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Appendix D 
Regions Demonstrating an Effect of Diagnosis by Update Trial Type Accuracy with the Whole Brain 
X Y Z Size Hemisphere Region BA Effect at frames 8-12 Correct vs. Incorrect 
      
Analysis F p Patients Controls 
Diagnosis 
1 -16 6 912 Right  Thalamus 
-45 23 6 239 Left  Inferior Frontal Gyrus 45 
25 28 -2 25 Right  Inferior Frontal Gyrus 47 
-30 20 3 50 Left  Insula 13 
32 15 4 46 Right  Insula 13 
-46 -4 33 204 Left  Precentral Gyrus 6 
49 -11 23 28 Right  Precentral Gyrus 6 
0 -29 29 33 Left  Cingulate Gyrus 23 
-27 -63 29 30 Left  Precuneus 7 
-39 -46 41 81 Left  Inferior Parietal Lobule 40 
-4 12 56 283 Left  Superior Frontal Gyrus 6 
-30 -1 52 33 Left  Middle Frontal Gyrus 6 
1 -29 67 66 Right  Paracentral Lobule 6 
-6 -21 -13 54 Left Brainstem Red Nucleus 
-28 -40 -43 32 Left Cerebellum Cerebellar Tonsil 
33 -69 -45 38 Right Cerebellum Inferior Semi-Lunar Lobule 
-29 -70 -46 52 Left Cerebellum Inferior Semi-Lunar Lobule 
Diagnosis X Accuracy 
-20 -21 2 39 Left  Thalamus Dx X Acc 10.98 0.002 no diff cor < incor** 
13 -25 2 25 Right  Thalamus Dx X Acc 8.63 0.006 no diff cor < incor* 
-5 -27 -11 27 Left Brainstem Red Nucleus Dx X Acc 5.43 0.03 cor > incor* cor < incor* 
Accuracy X Time 
0 42 -5 36 Left  Anterior Cingulate 32 
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-44 10 30 21 Left  Inferior Frontal Gyrus 9 
-36 -31 43 57 Left  Inferior Parietal Lobule 40 
23 24 40 59 Right  Middle Frontal Gyrus 8 
25 -4 44 56 Right  Middle Frontal Gyrus 6 
-27 1 50 124 Left  Middle Frontal Gyrus 6 
-24 -43 -9 33 Left  Parahippocampal Gyrus 36 
-20 -70 42 59 Left  Precuneus 7 
-3 15 55 203 Left  Superior Frontal Gyrus 6 
36 -41 9 30 Right  Superior Temporal Gyrus 41 
Diagnosis X Time 
-8 -70 32 33 Left  Cuneus 7 
52 -59 -18 27 Right  Fusiform Gyrus 37 
-40 44 3 124 Left  Inferior Frontal Gyrus 10 
-35 -45 45 21 Left  Inferior Parietal Lobule 40 
1 -92 -14 55 Right  Lingual Gyrus 18 
0 38 40 31 Left  Medial Frontal Gyrus 8 
-3 -26 65 26 Left  Medial Frontal Gyrus 6 
-43 8 47 48 Left  Middle Frontal Gyrus 6 
-55 11 9 23 Left  Precentral Gyrus 44 
-54 -3 20 23 Left  Precentral Gyrus 6 
42 17 35 22 Right  Precentral Gyrus 9 
29 -67 29 39 Right  Precuneus 19 
36 -42 37 23 Right  Sub-Gyral 40 
-6 12 60 120 Left  Superior Frontal Gyrus 6 
-48 -66 -16 30 Left Cerebellum Declive 
Diagnosis X Accuracy X Time 
25 42 5 23 Right  Medial Frontal Gyrus 10 Dx X Acc 2.33 0.14     
Regions within our anatomical masks from the current data set that demonstrated diagnosis by Update accuracy. They are organized on the 
left side under headings like “Diagnosis” or “Accuracy” based on whether they demonstrated these effects when examining all 15 time 
frames of the trial. We only conducted follow up analyses for the update cue period on regions that demonstrated a significant interaction of 
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accuracy and diagnosis. Statistics from the update cue response analysis can be found under the heading “Effect at frames 8-12”. “cor” = 
correct trials and “incor” = incorrect trials. *p<0.05 and **p<0.01, uncorrected. “no diff” signifies no statistically significant difference.
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Appendix E 
 
D’ Analysis of Behavioral Data 
We also examined our behavioral data using d’, where correct responses during Update 
trials were considered “hits” and incorrect responses during Resist Maintenance were 
considered “false alarms”. Both hits and false alarms were z-scored and then subtracted from 
one another (zHits-zFalse Alarms) to create the d’ of updating (UP_D’). Similarly, we created d’ 
using the same method for distracter trials by using correct responses of Resist Distracter trials 
as hits and incorrect responses of Resist Distracter Lure trials as false alarms (RM_D’). These 
two d’ prime variables give an account of the signal to noise ratio when participants are tasked 
with making an update or ignoring distracting information. Box plots of the d’ scores for each 
variable and each group can been seen in the figures below. To determine if d’ differed between 
trials and between groups we conduced a 2 x 2 ANOVA with trial d’ (UP_D’ and RM_D’) and 
diagnosis (patients and controls) as factors. We also included age and ethnicity as covariates, 
given that these demographic variables were found to differ between diagnostic groups. We 
found a significant main effect of diagnosis (F(1,38) = 16.99, p < 0.001), but no main effect of 
trial type (F(1,38) = 0.21, p = 0.65) and no interaction of trial type and diagnosis (F(1,38) = 1.39, 
p = 0.25). With regard to the effect of diagnosis, d’ scores for patients were lower than controls 
(as seen in the box plots). This was true for both trial conditions. We also examined the 
correlation between d’ and symptom scores separately for patients and controls. For patients, 
we found that RM_D’ did not correlate with any symptoms measures we examined (including 
aberrant salience). When examining UP_D’, we again did not find a significant correlation with 
aberrant salience, but found a significant negative correlation with physical anhedonia (r= -0.57, 
p = 0.005). For controls, however, we found significant negative correlations between RM_D’ 
and aberrant salience (r= -0.49, p = 0.03) and magical ideation (r= -0.57, p = 0.009), and 
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significant correlations between UP_D’ and aberrant salience (r= -0.52, p = 0.02) and magical 
ideation (r= -0.54, p = 0.006). 
 
Box plots of d’ scores for RM_D’ (top) and UP_D’ (bottom). Patients are group 1 and 
controls are group 2. Cases identified as outliers were examined and were found to be high 
performing patients for the RM_D’ condition and a patient who performed poorly during the false 
alarm trial for the UP_D’ condition. The upper and lower bound of the box represent the 75th and 
25th percentile, respectively. The dark line in the box represents the median for each group. 
Upper and lower whiskers represent the maximum and minimum values, respectively. Outliers 
were values that fell outside of 1.5 times the inner quartile range.
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Appendix F 
 
A Breakdown of the Number of Trials for Each Task Condition and Trial Type 
Upempty Upred Upgreen 
20 48 52 
SMAIN SMAINNP RMAIN RMAINUP RMAINNP UPDATE UPDATEOP UPDATENP UPDATEOP2 
14 6 20 20 8 20 20 8 4 
 
